<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="diabetes"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC6014560/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014560/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Diabetes"><meta name="citation_title" content="Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes"><meta name="citation_authors" content="Daniel M. Rotroff, Sook Wah Yee, Kaixin Zhou, Skylar W. Marvel, Hetal S. Shah, John R. Jack, Tammy M. Havener, Monique M. Hedderson, Michiaki Kubo, Mark A. Herman, He Gao, Josyf C. Mychaleckyi, Howard L. McLeod, Alessandro Doria, Kathleen M. Giacomini, Ewan R. Pearson, Michael J. Wagner, John B. Buse, Alison A. Motsinger-Reif, MetGen Investigators, ACCORD/ACCORDion Investigators"><meta name="citation_date" content="July 2018"><meta name="citation_issue" content="7"><meta name="citation_volume" content="67"><meta name="citation_firstpage" content="1428"><meta name="citation_doi" content="10.2337/db17-1164"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC6014560/?report=abstract"><meta name="citation_pmid" content="29650774"><meta name="DC.Title" content="Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="American Diabetes Association"><meta name="DC.Contributor" content="Daniel M. Rotroff"><meta name="DC.Contributor" content="Sook Wah Yee"><meta name="DC.Contributor" content="Kaixin Zhou"><meta name="DC.Contributor" content="Skylar W. Marvel"><meta name="DC.Contributor" content="Hetal S. Shah"><meta name="DC.Contributor" content="John R. Jack"><meta name="DC.Contributor" content="Tammy M. Havener"><meta name="DC.Contributor" content="Monique M. Hedderson"><meta name="DC.Contributor" content="Michiaki Kubo"><meta name="DC.Contributor" content="Mark A. Herman"><meta name="DC.Contributor" content="He Gao"><meta name="DC.Contributor" content="Josyf C. Mychaleckyi"><meta name="DC.Contributor" content="Howard L. McLeod"><meta name="DC.Contributor" content="Alessandro Doria"><meta name="DC.Contributor" content="Kathleen M. Giacomini"><meta name="DC.Contributor" content="Ewan R. Pearson"><meta name="DC.Contributor" content="Michael J. Wagner"><meta name="DC.Contributor" content="John B. Buse"><meta name="DC.Contributor" content="Alison A. Motsinger-Reif"><meta name="DC.Contributor" content="MetGen Investigators"><meta name="DC.Contributor" content="ACCORD/ACCORDion Investigators"><meta name="DC.Date" content="2018 Jul"><meta name="DC.Identifier" content="10.2337/db17-1164"><meta name="DC.Language" content="en"><meta property="og:title" content="Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes"><meta property="og:type" content="article"><meta property="og:description" content="Metformin is the first-line treatment for type 2 diabetes (T2D). Although widely prescribed, the glucose-lowering mechanism for metformin is incompletely understood. Here, we used a genome-wide association approach in a diverse group of individuals with ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014560/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-diabetes.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC6014560/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC6014560/pdf/db171164.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE88B3FEDD5AF39100000000060203A2.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6014560%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/582/">Diabetes</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/315752/">v.67(7); 2018 Jul</a></li><li class="accid">PMC6014560</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-diabetes.gif" alt="Logo of diabetes" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="197,11,264,38" alt="Subscribe" title="Subscribe" href="http://www.diabetesjournals.org/content/subscriptions" ref="reftype=publisher&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="197,39,264,66" alt="Search" title="Search" href="http://diabetes.diabetesjournals.org/" ref="reftype=publisher&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="265,0,500,75" alt="Diabetes Journal" title="Diabetes Journal" href="http://diabetes.diabetesjournals.org/" ref="reftype=publisher&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,196,75" alt="American Diabetes Association" title="American Diabetes Association" href="http://www.diabetes.org/" ref="reftype=publisher&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Diabetes</a></span>. 2018 Jul; 67(7): 1428–1440. </span></div><div><span class="fm-vol-iss-date">Published online 2018 Apr 12. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.2337%2Fdb17-1164" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.2337/db17-1164</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC6014560</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/29650774">29650774</a></div></div></div></div><h1 class="content-title">Genetic Variants in <em>CPA6</em> and <em>PRPF31</em> Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Rotroff%20DM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826693502960" co-class="co-affbox">Daniel M. Rotroff</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Yee%20SW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826685976448" co-class="co-affbox">Sook Wah Yee</a>,<sup>3</sup> <a href="/pubmed/?term=Zhou%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826679430336" co-class="co-affbox">Kaixin Zhou</a>,<sup>4</sup> <a href="/pubmed/?term=Marvel%20SW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826682180432" co-class="co-affbox">Skylar W. Marvel</a>,<sup>1</sup> <a href="/pubmed/?term=Shah%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826687384320" co-class="co-affbox">Hetal S. Shah</a>,<sup>5</sup> <a href="/pubmed/?term=Jack%20JR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826689556432" co-class="co-affbox">John R. Jack</a>,<sup>1</sup> <a href="/pubmed/?term=Havener%20TM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826691241120" co-class="co-affbox">Tammy M. Havener</a>,<sup>6</sup> <a href="/pubmed/?term=Hedderson%20MM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826690322592" co-class="co-affbox">Monique M. Hedderson</a>,<sup>7</sup> <a href="/pubmed/?term=Kubo%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826730394032" co-class="co-affbox">Michiaki Kubo</a>,<sup>8</sup> <a href="/pubmed/?term=Herman%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826686691904" co-class="co-affbox">Mark A. Herman</a>,<sup>9</sup> <a href="/pubmed/?term=Gao%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826688832672" co-class="co-affbox">He Gao</a>,<sup>5</sup> <a href="/pubmed/?term=Mychaleckyi%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826691646624" co-class="co-affbox">Josyf C. Mychaleckyi</a>,<sup>10</sup> <a href="/pubmed/?term=McLeod%20HL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826689141440" co-class="co-affbox">Howard L. McLeod</a>,<sup>11</sup> <a href="/pubmed/?term=Doria%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826697960240" co-class="co-affbox">Alessandro Doria</a>,<sup>5</sup> <a href="/pubmed/?term=Giacomini%20KM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826686210624" co-class="co-affbox">Kathleen M. Giacomini</a>,<sup>3</sup> <a href="/pubmed/?term=Pearson%20ER%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826688359648" co-class="co-affbox">Ewan R. Pearson</a>,<sup>4</sup> <a href="/pubmed/?term=Wagner%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826684843616" co-class="co-affbox">Michael J. Wagner</a>,<sup>6</sup> <a href="/pubmed/?term=Buse%20JB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826766798256" co-class="co-affbox">John B. Buse</a>,<sup>12</sup> <a href="/pubmed/?term=Motsinger-Reif%20AA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774" class="affpopup" co-rid="_co_idm139826687145152" co-class="co-affbox">Alison A. Motsinger-Reif</a>,<sup>1,</sup><sup>2</sup><sup></sup> MetGen Investigators, and  ACCORD/ACCORDion Investigators</div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139826693502960"><h3 class="no_margin">Daniel M. Rotroff</h3><p><sup>1</sup>Bioinformatics Research Center, North Carolina State University, Raleigh, NC</p><p><sup>2</sup>Department of Statistics, North Carolina State University, Raleigh, NC</p><div>Find articles by <a href="/pubmed/?term=Rotroff%20DM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Daniel M. Rotroff</a></div></div><div id="_co_idm139826685976448"><h3 class="no_margin">Sook Wah Yee</h3><p><sup>3</sup>Department of Bioengineering and Therapeutic Sciences and Institute for Human Genetics, University of California, San Francisco, San Francisco, CA</p><div>Find articles by <a href="/pubmed/?term=Yee%20SW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Sook Wah Yee</a></div></div><div id="_co_idm139826679430336"><h3 class="no_margin">Kaixin Zhou</h3><p><sup>4</sup>School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland</p><div>Find articles by <a href="/pubmed/?term=Zhou%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Kaixin Zhou</a></div></div><div id="_co_idm139826682180432"><h3 class="no_margin">Skylar W. Marvel</h3><p><sup>1</sup>Bioinformatics Research Center, North Carolina State University, Raleigh, NC</p><div>Find articles by <a href="/pubmed/?term=Marvel%20SW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Skylar W. Marvel</a></div></div><div id="_co_idm139826687384320"><h3 class="no_margin">Hetal S. Shah</h3><p><sup>5</sup>Joslin Diabetes Center and Harvard Medical School, Boston, MA</p><div>Find articles by <a href="/pubmed/?term=Shah%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Hetal S. Shah</a></div></div><div id="_co_idm139826689556432"><h3 class="no_margin">John R. Jack</h3><p><sup>1</sup>Bioinformatics Research Center, North Carolina State University, Raleigh, NC</p><div>Find articles by <a href="/pubmed/?term=Jack%20JR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">John R. Jack</a></div></div><div id="_co_idm139826691241120"><h3 class="no_margin">Tammy M. Havener</h3><p><sup>6</sup>Center for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC</p><div>Find articles by <a href="/pubmed/?term=Havener%20TM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Tammy M. Havener</a></div></div><div id="_co_idm139826690322592"><h3 class="no_margin">Monique M. Hedderson</h3><p><sup>7</sup>Division of Research, Kaiser Permanente Northern California, Oakland, CA</p><div>Find articles by <a href="/pubmed/?term=Hedderson%20MM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Monique M. Hedderson</a></div></div><div id="_co_idm139826730394032"><h3 class="no_margin">Michiaki Kubo</h3><p><sup>8</sup>RIKEN Center for Integrative Medical Science, Yokohama, Japan</p><div>Find articles by <a href="/pubmed/?term=Kubo%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Michiaki Kubo</a></div></div><div id="_co_idm139826686691904"><h3 class="no_margin">Mark A. Herman</h3><p><sup>9</sup>Department of Medicine, Duke University, Durham, NC</p><div>Find articles by <a href="/pubmed/?term=Herman%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Mark A. Herman</a></div></div><div id="_co_idm139826688832672"><h3 class="no_margin">He Gao</h3><p><sup>5</sup>Joslin Diabetes Center and Harvard Medical School, Boston, MA</p><div>Find articles by <a href="/pubmed/?term=Gao%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">He Gao</a></div></div><div id="_co_idm139826691646624"><h3 class="no_margin">Josyf C. Mychaleckyi</h3><p><sup>10</sup>Center for Public Health Genomics, University of Virginia, Charlottesville, VA</p><div>Find articles by <a href="/pubmed/?term=Mychaleckyi%20JC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Josyf C. Mychaleckyi</a></div></div><div id="_co_idm139826689141440"><h3 class="no_margin">Howard L. McLeod</h3><p><sup>11</sup>Moffitt Cancer Center, Tampa, FL</p><div>Find articles by <a href="/pubmed/?term=McLeod%20HL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Howard L. McLeod</a></div></div><div id="_co_idm139826697960240"><h3 class="no_margin">Alessandro Doria</h3><p><sup>5</sup>Joslin Diabetes Center and Harvard Medical School, Boston, MA</p><div>Find articles by <a href="/pubmed/?term=Doria%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Alessandro Doria</a></div></div><div id="_co_idm139826686210624"><h3 class="no_margin">Kathleen M. Giacomini</h3><p><sup>3</sup>Department of Bioengineering and Therapeutic Sciences and Institute for Human Genetics, University of California, San Francisco, San Francisco, CA</p><div>Find articles by <a href="/pubmed/?term=Giacomini%20KM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Kathleen M. Giacomini</a></div></div><div id="_co_idm139826688359648"><h3 class="no_margin">Ewan R. Pearson</h3><p><sup>4</sup>School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland</p><div>Find articles by <a href="/pubmed/?term=Pearson%20ER%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Ewan R. Pearson</a></div></div><div id="_co_idm139826684843616"><h3 class="no_margin">Michael J. Wagner</h3><p><sup>6</sup>Center for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC</p><div>Find articles by <a href="/pubmed/?term=Wagner%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Michael J. Wagner</a></div></div><div id="_co_idm139826766798256"><h3 class="no_margin">John B. Buse</h3><p><sup>12</sup>Division of Endocrinology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC</p><div>Find articles by <a href="/pubmed/?term=Buse%20JB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">John B. Buse</a></div></div><div id="_co_idm139826687145152"><h3 class="no_margin">Alison A. Motsinger-Reif</h3><p><sup>1</sup>Bioinformatics Research Center, North Carolina State University, Raleigh, NC</p><p><sup>2</sup>Department of Statistics, North Carolina State University, Raleigh, NC</p><div>Find articles by <a href="/pubmed/?term=Motsinger-Reif%20AA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29650774">Alison A. Motsinger-Reif</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139826689876208_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139826689876208_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139826689876208_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139826689876208_ai" style="display:none"><div class="fm-affl" id="aff1" lang="en"><sup>1</sup>Bioinformatics Research Center, North Carolina State University, Raleigh, NC</div><div class="fm-affl" id="aff2" lang="en"><sup>2</sup>Department of Statistics, North Carolina State University, Raleigh, NC</div><div class="fm-affl" id="aff3" lang="en"><sup>3</sup>Department of Bioengineering and Therapeutic Sciences and Institute for Human Genetics, University of California, San Francisco, San Francisco, CA</div><div class="fm-affl" id="aff4" lang="en"><sup>4</sup>School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland</div><div class="fm-affl" id="aff5" lang="en"><sup>5</sup>Joslin Diabetes Center and Harvard Medical School, Boston, MA</div><div class="fm-affl" id="aff6" lang="en"><sup>6</sup>Center for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, NC</div><div class="fm-affl" id="aff7" lang="en"><sup>7</sup>Division of Research, Kaiser Permanente Northern California, Oakland, CA</div><div class="fm-affl" id="aff8" lang="en"><sup>8</sup>RIKEN Center for Integrative Medical Science, Yokohama, Japan</div><div class="fm-affl" id="aff9" lang="en"><sup>9</sup>Department of Medicine, Duke University, Durham, NC</div><div class="fm-affl" id="aff10" lang="en"><sup>10</sup>Center for Public Health Genomics, University of Virginia, Charlottesville, VA</div><div class="fm-affl" id="aff11" lang="en"><sup>11</sup>Moffitt Cancer Center, Tampa, FL</div><div class="fm-affl" id="aff12" lang="en"><sup>12</sup>Division of Endocrinology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC</div><div id="cor1">Corresponding author: Alison A. Motsinger-Reif, <a href="mailto:dev@null" data-email="ude.uscn@regnistom_nosila" class="oemail">ude.uscn@regnistom_nosila</a>.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139826689876208_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2017 Oct 18; Accepted 2018 Apr 2.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139826689876208_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © 2018 by the American Diabetes Association.</div><div class="license half_rhythm">Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at <a href="http://www.diabetesjournals.org/content/license" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://www.diabetesjournals.org/content/license</a>.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC6014560/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">
Supplementary Data
</div>

<div><a href="/pmc/articles/PMC6014560/bin/DB171164SupplementaryData.pdf" data-ga-action="click_feat_suppl">DB171164SupplementaryData.pdf</a><span style="color:gray"> (800K)</span></div><div class="small guid">GUID:&nbsp;B863FBF7-0B25-4897-984B-DFB76EC5F242</div>
</div></dd></dl></div><div id="idm139826690703824" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139826690703824title">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first-last">Metformin is the first-line treatment for type 2 diabetes (T2D). Although widely prescribed, the glucose-lowering mechanism for metformin is incompletely understood. Here, we used a genome-wide association approach in a diverse group of individuals with T2D from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial to identify common and rare variants associated with HbA<sub>1c</sub> response to metformin treatment and followed up these findings in four replication cohorts. Common variants in <em>PRPF31</em> and <em>CPA6</em> were associated with worse and better metformin response, respectively (<em>P</em> &lt; 5 × 10<sup>−6</sup>), and meta-analysis in independent cohorts displayed similar associations with metformin response (<em>P</em> = 1.2 × 10<sup>−8</sup> and <em>P</em> = 0.005, respectively). Previous studies have shown that <em>PRPF31</em>(+/−) knockout mice have increased total body fat (<em>P</em> = 1.78 × 10<sup>−6</sup>) and increased fasted circulating glucose (<em>P</em> = 5.73 × 10<sup>−6</sup>). Furthermore, rare variants in <em>STAT3</em> associated with worse metformin response (<em>q</em> &lt;0.1). STAT3 is a ubiquitously expressed pleiotropic transcriptional activator that participates in the regulation of metabolism and feeding behavior. Here, we provide novel evidence for associations of common and rare variants in <em>PRPF31, CPA6,</em> and <em>STAT3</em> with metformin response that may provide insight into mechanisms important for metformin efficacy in T2D.</p></div></div><div id="s1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s1title">Introduction</h2><p id="__p2" class="p p-first">The incidence of type 2 diabetes (T2D) is increasing and the Centers for Disease Control and Prevention estimate that 11% of U.S. adults, aged 20 years or older, have diagnosed or undiagnosed T2D, and 35% of people in the same age-group have prediabetes based on fasting glucose or hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) levels (<a href="#B1" rid="B1" class=" bibr popnode">1</a>). T2D is now considered a global epidemic with prevalence increasing from 108 million in 1980 to 422 million in 2014 (<a href="#B2" rid="B2" class=" bibr popnode">2</a>). Individuals with T2D are at an increased risk of developing blindness and kidney failure and are at risk for lower-limb amputations. Furthermore, individuals with T2D are 2–4 times more likely to develop cardiovascular disease (CVD), including heart attack and stroke (<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306635">3</a>).</p><p id="__p3">Metformin, a member of the biguanide class of drugs, is now considered first-line therapy for individuals with T2D (<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306643">4</a>). Despite intensive investigation, the molecular mechanisms mediating metformin’s beneficial effects on glycemic control remain controversial and poorly understood. Studies performed predominantly in animal models have implicated various mechanisms and molecules as participating in metformin’s beneficial effects, including direct inhibitory effects on mitochondrial function, activation of hepatic AMPK, and alterations in glucagon signaling pathways (<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306634">5</a>–<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306629">10</a>). The relative importance of these mechanisms for metformin’s beneficial effects on glycemic control in humans is unclear.</p><p id="__p4">There is significant interindividual variability in response to metformin (<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306633">11</a>–<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306655">13</a>). This suggests that a better understanding of the mechanisms by which metformin functions might allow for more tailored and precise treatment. Studies suggest that heritable factors contribute to this variability, which provides an opportunity to identify causal genetic contributors through genetic association studies (<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306622">11</a>). Recent genome-wide association studies (GWAS) have identified common variants that affected metformin response in the <em>ATM</em> locus, which has been shown to activate AMPK, and the <em>SLC2A2</em> locus, which encodes the facilitated glucose transporter, GLUT2 (<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306624">12</a>,<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306650">13</a>). Here, we use a GWAS approach in a large cohort of individuals with T2D in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial to test for associations of both common and rare variant single nucleotide polymorphisms (SNPs) with change in HbA<sub>1c</sub> in response to metformin treatment.</p><p id="__p5" class="p p-last">The ACCORD trial followed 10,251 participants for up to 8 years at 77 clinical centers in the U.S. and Canada to compare the benefits and risks of treatment strategies for intensively targeting glycemia, blood pressure, and dyslipidemia versus standard targets in individuals with T2D at high risk for CVD (<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306649">14</a>–<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306659">17</a>). No overall benefit and possible harms were observed in the combined primary CVD end points with intensive glucose-lowering therapy. However, significant variability in treatment response was also observed, highlighting the potential for identifying genetic markers of drug response that may lead to the development of improved and personalized treatment strategies. The results presented here point to novel mechanisms of metformin drug response and potential therapeutic targets for the treatment of T2D.</p></div><div id="s2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s2title">Research Design and Methods</h2><div id="s3" class="sec sec-first"><h3 id="s3title">Study Participants</h3><p id="__p6" class="p p-first">The ACCORD trial (<a href="http://ClinicalTrials.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">ClinicalTrials.gov</a> identifier: <a id="__tag_708306761" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00000620" ref="reftype=extlink-clinical-trial&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00000620","term_id":"NCT00000620"}}</span>NCT00000620</a>) was a double 2 × 2 factorial design comparing intensive versus standard treatment approaches for controlling glycemia, blood pressure, and dyslipidemia that enrolled 10,251 patients with T2D with a history of CVD or at least two known risk factors for CVD, such as documented atherosclerosis, albuminuria, dyslipidemia, hypertension, smoking, or obesity (<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306626">14</a>). Additional details about randomization and selection criteria for the various arms of the ACCORD trial can be found in the <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Data</a>. Participants in ACCORD were given an option to provide a blood sample for future genetic studies, and over 80% of participants agreed to do so. A workflow describing the selection of subjects can be found in <a href="/pmc/articles/PMC6014560/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>. Additional demographic information can be found in <a href="/pmc/articles/PMC6014560/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC6014560/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139826693360928" class="figure"><a href="/pmc/articles/PMC6014560/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6014560_db171164f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is db171164f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6014560/bin/db171164f1.jpg"></a></div><div id="largeobj_idm139826693360928" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC6014560/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC6014560/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p7">Study design and quality control (QC) workflow. Boxes represent the steps taken in the workflow. The number of remaining subjects after a quality control step can be found in the relevant attached circle.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p8">Cohort demographics and concomitant medications</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139826691280544" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th scope="col" rowspan="1" colspan="1" align="left"></th><th scope="col" rowspan="1" colspan="1" align="center">All races combined<br>(<em>N</em> = 1,312)</th><th scope="col" rowspan="1" colspan="1" align="center">White subjects only<br>(<em>N</em> = 845)</th><th scope="col" rowspan="1" colspan="1" align="center">Black subjects only<br>(<em>N</em> = 222)</th></tr></thead><tbody><tr><td scope="row" rowspan="1" colspan="1" align="left">Intensive glycemia arm<hr></td><td rowspan="1" colspan="1" align="center">56.33<hr></td><td rowspan="1" colspan="1" align="center">59.41<hr></td><td rowspan="1" colspan="1" align="center">53.15<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">Standard glycemia arm<hr></td><td rowspan="1" colspan="1" align="center">43.67<hr></td><td rowspan="1" colspan="1" align="center">40.59<hr></td><td rowspan="1" colspan="1" align="center">46.85<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">Intensive blood pressure arm<hr></td><td rowspan="1" colspan="1" align="center">23.86<hr></td><td rowspan="1" colspan="1" align="center">23.67<hr></td><td rowspan="1" colspan="1" align="center">34.23<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">Standard blood pressure arm <hr></td><td rowspan="1" colspan="1" align="center">23.78<hr></td><td rowspan="1" colspan="1" align="center">21.89<hr></td><td rowspan="1" colspan="1" align="center">33.33<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">Fibrate lipid treatment arm<hr></td><td rowspan="1" colspan="1" align="center">25.99<hr></td><td rowspan="1" colspan="1" align="center">25.68<hr></td><td rowspan="1" colspan="1" align="center">14.41<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">Placebo lipid treatment arm <hr></td><td rowspan="1" colspan="1" align="center">26.37<hr></td><td rowspan="1" colspan="1" align="center">28.76<hr></td><td rowspan="1" colspan="1" align="center">18.01<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">Female<hr></td><td rowspan="1" colspan="1" align="center">39.48<hr></td><td rowspan="1" colspan="1" align="center">36.33<hr></td><td rowspan="1" colspan="1" align="center">52.70<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">Age (mean [95% CI])<hr></td><td rowspan="1" colspan="1" align="center">62.72 [62.36, 63.10]<hr></td><td rowspan="1" colspan="1" align="center">63.14 [62.70, 63.58]<hr></td><td rowspan="1" colspan="1" align="center">62.25 [61.37, 63.12]<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">BMI (mean [95% CI])<hr></td><td rowspan="1" colspan="1" align="center">32.43 [32.13, 32.73]<hr></td><td rowspan="1" colspan="1" align="center">33.18 [32.82, 33.54]<hr></td><td rowspan="1" colspan="1" align="center">32.67 [31.94, 33.39]<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">Years with T2D (mean [95% CI])<hr></td><td rowspan="1" colspan="1" align="center">10.10 [9.67, 10.51]<hr></td><td rowspan="1" colspan="1" align="center">9.73 [9.23, 10.24]<hr></td><td rowspan="1" colspan="1" align="center">10.82 [9.76, 11.87]<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">History of cardiovascular disease<hr></td><td rowspan="1" colspan="1" align="center">33.54<hr></td><td rowspan="1" colspan="1" align="center">35.27<hr></td><td rowspan="1" colspan="1" align="center">29.28<hr></td></tr><tr><td colspan="4" scope="col" rowspan="1" align="left">Concomitant medications<sup>*</sup><hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Angiotensin type 2 antagonists<hr></td><td rowspan="1" colspan="1" align="center">16.39<hr></td><td rowspan="1" colspan="1" align="center">15.98<hr></td><td rowspan="1" colspan="1" align="center">16.67<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> ACE inhibitors<hr></td><td rowspan="1" colspan="1" align="center">46.19<hr></td><td rowspan="1" colspan="1" align="center">46.98<hr></td><td rowspan="1" colspan="1" align="center">52.25<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> α-Glucosidase inhibitors<hr></td><td rowspan="1" colspan="1" align="center">0.53<hr></td><td rowspan="1" colspan="1" align="center">0.47<hr></td><td rowspan="1" colspan="1" align="center">0.45<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Cholesterol absorption inhibitors<hr></td><td rowspan="1" colspan="1" align="center">2.13<hr></td><td rowspan="1" colspan="1" align="center">2.49<hr></td><td rowspan="1" colspan="1" align="center">1.80<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Statin<hr></td><td rowspan="1" colspan="1" align="center">49.70<hr></td><td rowspan="1" colspan="1" align="center">51.83<hr></td><td rowspan="1" colspan="1" align="center">30.18<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Lisinopril<hr></td><td rowspan="1" colspan="1" align="center">16.46<hr></td><td rowspan="1" colspan="1" align="center">16.45<hr></td><td rowspan="1" colspan="1" align="center">25.23<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Loop diuretics<hr></td><td rowspan="1" colspan="1" align="center">8.23<hr></td><td rowspan="1" colspan="1" align="center">8.99<hr></td><td rowspan="1" colspan="1" align="center">10.36<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Meglitinides<hr></td><td rowspan="1" colspan="1" align="center">2.97<hr></td><td rowspan="1" colspan="1" align="center">2.37<hr></td><td rowspan="1" colspan="1" align="center">3.15<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Nitrates<hr></td><td rowspan="1" colspan="1" align="center">5.72<hr></td><td rowspan="1" colspan="1" align="center">6.51<hr></td><td rowspan="1" colspan="1" align="center">3.60<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Other diabetes treatments<hr></td><td rowspan="1" colspan="1" align="center">2.67<hr></td><td rowspan="1" colspan="1" align="center">2.84<hr></td><td rowspan="1" colspan="1" align="center">4.05<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Sulfonylureas<hr></td><td rowspan="1" colspan="1" align="center">52.44<hr></td><td rowspan="1" colspan="1" align="center">51.83<hr></td><td rowspan="1" colspan="1" align="center">45.05<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Thiazolidinediones<hr></td><td rowspan="1" colspan="1" align="center">31.63<hr></td><td rowspan="1" colspan="1" align="center">33.02<hr></td><td rowspan="1" colspan="1" align="center">29.28<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left"> Insulin</td><td rowspan="1" colspan="1" align="center">38.11</td><td rowspan="1" colspan="1" align="center">38.11</td><td rowspan="1" colspan="1" align="center">45.95</td></tr></tbody></table></div><div id="largeobj_idm139826691280544" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC6014560/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="idm139826693632160"><p id="__p9" class="p p-first-last">Data are %, unless stated otherwise.</p></div><div id="t1n1"><p id="__p10" class="p p-first-last">*Tabulated percentages represent the percentage of subjects with at least one record of taking the medication or a medication in the drug class during the metformin treatment window. This is not an exhaustive list of medications recorded in ACCORD, but rather a representative list of the commonly used medications in ACCORD.</p></div></div></div></div><div id="s4" class="sec"><h3 id="s4title">Phenotype Definitions</h3><p id="__p11" class="p p-first-last">Glycemic response to metformin was evaluated in subjects who began taking metformin while enrolled in ACCORD; subjects who reported taking metformin or another biguanide prior to enrollment in the trial were excluded. Some subjects were taking additional medications and were accounted for as described in the <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Data</a> and Graham et al. (<a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708700968">18</a>). Subjects were scheduled for study visits every 1 or 4 months based on randomization to the intensive or standard glycemia arms, respectively. HbA<sub>1c</sub> was recorded every 4 months. Metformin response was calculated as on-treatment HbA<sub>1c</sub> minus pretreatment HbA<sub>1c</sub>. Pretreatment HbA<sub>1c</sub> levels were recorded no more than 30 days prior to the start of metformin. On-treatment HbA<sub>1c</sub> levels were defined as the first recorded measurement acquired after at least 90 days and no more than 270 days from the start of metformin treatment. This interval was chosen to allow for HbA<sub>1c</sub> levels to stabilize after starting metformin, while limiting changes in glycemia levels due to additional modifications to treatment regimens. Medication compliance and other details regarding the phenotype definition can be found in the <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Data</a>.</p></div><div id="s5" class="sec"><h3 id="s5title">Genotyping</h3><p id="__p12" class="p p-first-last">Briefly, 6,085 unique samples from ACCORD participants who consented to genetic studies conducted by any investigator were genotyped at the University of Virginia on Illumina HumanOmniExpressExome-8 v1.0 chips (Set 1); 8,174 unique samples, including the above 6,085 samples plus 2,089 samples from ACCORD participants who consented to genetic studies only if conducted by ACCORD investigators, were genotyped at the University of North Carolina on Affymetrix Axiom Biobank1 chips (Set 2). The data were then merged, resulting in one data set consisting of 5,971 samples genotyped at a total of 1,240,656 individual SNPs, and another with an additional 2,083 samples genotyped at 583,613 SNPs. Additional details can be found in the <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Data</a> and Marvel et al. (<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708700965">19</a>).</p></div><div id="s6" class="sec sec-last"><h3 id="s6title">Data Processing</h3><div id="s7" class="sec sec-first"><p></p><h4 id="s7title" class="inline">Covariate Selection </h4><p id="__p13" class="p p-first-last">We implemented a variable selection procedure to address potential confounding. Some variables were included in the model based on previous studies or expert knowledge, whereas other variables were selected based on a backward selection approach and Bayesian information criteria to identify covariates specific to the ACCORD data set. All covariate names and descriptions before variable selection can be found in <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 1</a>. A substantial proportion of the cohort was taking other medications during the metformin treatment response time frame and these concomitant medications were incorporated into the model as described in the <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Data</a>. To prevent confounding due to population substructure, principal component analysis was performed based on the genotype data using EIGENSTRAT (v4.2) and is described in the <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Data</a>. The final models after covariate selection can be found in <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Tables 2–4</a>. A workflow detailing each step of the analysis can be found in <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Fig. 4</a>.</p></div><div id="s8" class="sec"><p></p><h4 id="s8title" class="inline">Common Variant Analysis </h4><p id="__p14" class="p p-first-last">Associations between a phenotype, covariates, and single common variant (minor allele frequency [MAF] &gt;3%) were tested using the linear regression model. Genotyped variants were tested as an additive variable using PLINK, where <img alt="An external file that holds a picture, illustration, etc.
Object name is db171164inf1.jpg" src="/pmc/articles/PMC6014560/bin/db171164inf1.jpg" class="equation"> is the number of minor alleles for the <img alt="An external file that holds a picture, illustration, etc.
Object name is db171164inf2.jpg" src="/pmc/articles/PMC6014560/bin/db171164inf2.jpg" class="equation"><sup>th</sup> individual. Imputed variants were tested using a linear regression model in the statistical programming language, R, where <img alt="An external file that holds a picture, illustration, etc.
Object name is db171164inf3.jpg" src="/pmc/articles/PMC6014560/bin/db171164inf3.jpg" class="equation"> is the dosage score computed from the posterior probabilities for genotypes <img alt="An external file that holds a picture, illustration, etc.
Object name is db171164inf4.jpg" src="/pmc/articles/PMC6014560/bin/db171164inf4.jpg" class="equation"> and <img alt="An external file that holds a picture, illustration, etc.
Object name is db171164inf5.jpg" src="/pmc/articles/PMC6014560/bin/db171164inf5.jpg" class="equation"> (<a href="#B20" rid="B20" class=" bibr popnode">20</a>). For SNPs that were only genotyped in Set 1 subjects and were imputed in Set 2 subjects, association tests were calculated for each set separately and the results were combined by meta-analysis using PLINK (<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306632">21</a>,<a href="#B22" rid="B22" class=" bibr popnode">22</a>). Tables and figures specify whether each result derives from a SNP that was genotyped in all subjects, imputed in all subjects, or represents a combination of genotyped and imputed data using the meta-analysis approach described.</p></div><div id="s9" class="sec"><p></p><h4 id="s9title" class="inline">Rare Variant Analysis </h4><p id="__p15" class="p p-first-last">The rare variant analysis approach has been previously described (<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708700967">19</a>). Briefly, all variants (MAF ≤3%) were mapped to gene annotation from Ensemble (GRCh37.p13). A suite of five rare variant tests comprised of burden and nonburden were then used to assess associations with metformin response. We combined the set of five <em>P</em> values from each test into a single <em>P</em> value for each gene using the procedure described by Dai et al. (<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708700966">23</a>). Subsequently, the combined <em>P</em> value was corrected for multiple comparisons with a false discovery rate approach (<a href="#B24" rid="B24" class=" bibr popnode">24</a>,<a href="#B25" rid="B25" class=" bibr popnode">25</a>), and a threshold of <em>q</em> &lt;0.1 was used for statistical significance.</p></div><div id="s10" class="sec"><p></p><h4 id="s10title" class="inline">Replication of ACCORD Results </h4><p id="__p16" class="p p-first">SNPs that associated with metformin response in the common variant analyses (<em>P</em> &lt; 5 × 10<sup>−6</sup>) were tested for associations in the following cohorts. There was one cohort from European ancestry, which included combined samples from Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS) and PMET1-EU (Pharmacogenomics of Metformin, cohort 1, of European ancestry; PMET1 was previously named PMT2) (REP1) (<em>n</em> = 6,963). There were two cohorts from African American ancestry, referred to as REP2 (<em>n</em> = 646) and REP3 (<em>n</em> = 369). Briefly, the GoDARTS cohort in REP1 has been described before by the <em>Wellcome Trust Case Control Consortium 2</em> (<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306654">13</a>). The REP2 cohort was collected from two main clinical sites, Kaiser Permanente Northern California and Kaiser Permanente South East, as previously described (<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306631">26</a>). The PMET1-EU in REP1 and the REP3 cohorts were collected from the Research Program on Genes, Environment and Health (RPGEH), based at Kaiser Permanente Northern California (<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306658">27</a>). Metformin response for REP1 was defined as pretreatment HbA<sub>1c</sub> minus posttreatment HbA<sub>1c</sub>, resulting in effects that are in the opposite direction of those in ACCORD. Because of this, the additive inverse of effect sizes in REP1 was used in the analysis with ACCORD results. For REP2 and REP3, metformin response was calculated as posttreatment HbA<sub>1c</sub> minus pretreatment HbA<sub>1c</sub>.</p><p id="__p17">To provide additional support for the role of the lead SNP, rs57081354, in modulating metformin action, we performed an association test between rs57081354 and baseline HbA<sub>1c</sub> in ACCORD individuals that were already on metformin at the start of the trial (REP4) and compared those results to the association of baseline HbA<sub>1c</sub> in individuals not on metformin at the start of the trial. All individuals in REP4 were excluded from the discovery cohort due to the lack of a recorded pretreatment HbA<sub>1c</sub>, making it impossible to calculate a change in HbA<sub>1c</sub> with treatment. For this analysis, an association test was performed as described in the common variant analysis with the exception of the phenotype being baseline level of HbA<sub>1c</sub> rather than change in HbA<sub>1c</sub>.</p><p id="__p18" class="p p-last">Each SNP with <em>P</em> &lt; 5 × 10<sup>−8</sup> in the discovery cohort or with <em>P</em> &lt; 5 × 10<sup>−6</sup> in the discovery cohort and <em>q</em> &lt;0.01 in at least one replication cohort were meta-analyzed across available cohorts using PLINK (<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306656">21</a>,<a href="#B22" rid="B22" class=" bibr popnode">22</a>). Meta-analysis with <em>P</em> &lt; 0.05 was considered to be statistically significant. Additional information regarding each cohort can be found in the <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Data</a>, and a workflow describing how the replication was evaluated can be found in <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Fig. 4</a>.</p></div><div id="s11" class="sec sec-last"><p></p><h4 id="s11title" class="inline">Dietary Analysis </h4><p id="__p19" class="p p-first-last">Dietary questionnaires were assessed for 1,600 participants that both consented to genotyping and had dietary records as part of the Health-Related Quality of Life substudy within ACCORD. Scores in response to the dietary questionnaires were tested for association with the lead SNP, rs57081354, using a linear regression model and the same covariate selection process as described above. Details regarding this analysis can be found in the <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Data</a>.</p></div></div></div><div id="s12" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s12title">Results</h2><p id="__p20" class="p p-first">A total of 1,312, 845, and 222 subjects were included in the common and rare variant analyses for all races combined, white, and black cohorts, respectively (<a href="/pmc/articles/PMC6014560/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>). Other racial groups were included in the all races combined group, but sample sizes were too small to perform stratified analyses. Variation was observed in HbA<sub>1c</sub> response (<a href="/pmc/articles/PMC6014560/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a>). The mean change in HbA<sub>1c</sub> was −1.42% (95% CI −1.49, −1.36) for all races combined, −1.47% (−1.55, −1.39) for white subjects only, and −1.35% (−1.50, −1.19) for black subjects only. The difference in the change in HbA<sub>1c</sub> between white and black subjects was not statistically significant (<em>P</em> = 0.16). Variables selected as being significantly associated with metformin response explained approximately 55% of the variation in metformin response and were subsequently included in the common and rare variant analyses (<a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Tables 2–4</a>). Briefly, assignment to the intensive glycemia arm of the ACCORD trial, years with T2D, and pretreatment HbA<sub>1c</sub> were significantly associated with metformin response in all tested groups.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC6014560/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139826682585312" class="figure"><a href="/pmc/articles/PMC6014560/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6014560_db171164f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is db171164f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6014560/bin/db171164f2.jpg"></a></div><div id="largeobj_idm139826682585312" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC6014560/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC6014560/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p21">Distributions of HbA<sub>1c</sub> response to metformin treatment. <em>A</em>: HbA<sub>1c</sub> response when all races are combined. <em>B</em>: HbA<sub>1c</sub> response in only white participants. <em>C</em>: HbA<sub>1c</sub> response in only black participants.</p></div></div></div><div id="s13" class="sec"><h3 id="s13title">Common Variant Analysis</h3><p id="__p22" class="p p-first">A total of 316,203 genotyped, 547,639 meta-analyzed, and 7,567,403 imputed variants had MAF &gt;3% and were included in the common variant analysis when all races were combined. A total of 1, 3, and 7 SNPs were significantly associated with HbA<sub>1c</sub> response in all races combined, white subjects only, and black subjects only, respectively (<em>P</em> &lt; 5 × 10<sup>−8</sup>). In all subjects combined, the lead SNP rs57081354 located within an intron in the <em>NBEA</em> gene associated with HbA<sub>1c</sub> response (<a href="/pmc/articles/PMC6014560/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a>). Sixty-five SNPs in 16 loci on 14 different chromosomes (in genes <em>NBEA</em>, <em>LOC105374140</em>, <em>CXCL13</em>, <em>MCC</em>, <em>FAM189A1</em>, <em>LOC107984525</em>, <em>LOC105379109</em>, <em>KIAA1024</em>, <em>RBFOX1</em>, <em>LOC643339</em>, <em>UBOX5</em>, <em>NR2C1</em>, <em>BPHL</em>, <em>PRPF31</em>, <em>LOC105377165</em>, and <em>ADAMTS9-AS2</em>) reached the threshold for suggestive significance (<em>P</em> &lt; 5 × 10<sup>−6</sup>). For white subjects only, 3 SNPs in <em>KIAA1024</em> were associated with HbA<sub>1c</sub> response at genome-wide levels of significance (<em>P</em> &lt; 5 × 10<sup>−8</sup>), and 23 SNPs in 7 loci (in genes <em>KIAA1024</em>, <em>LOC283177</em>, <em>LOC105377165</em>, <em>ADAMTS9-AS2</em>, <em>CPA6</em>, <em>NR2C1</em>, and <em>DPYD</em>) reached the threshold for suggestive significance (<em>P</em> &lt; 5 × 10<sup>−6</sup>) (<a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Fig. 1</a>). When black subjects were analyzed separately, 2 SNPs in the <em>LOC102724874</em> locus were associated with HbA<sub>1c</sub> response at genome-wide levels (<em>P</em> &lt; 5 × 10<sup>−8</sup>), and 53 SNPs in 8 loci (in genes <em>LOC102724874</em>, <em>LOC105374308</em>, <em>LOC105369406</em>, <em>SLC35D3</em>, <em>RHPN2</em>, <em>ETS1</em>, <em>SDK2</em>, and <em>GPC6</em>) reached the threshold for suggestive significance (<em>P</em> &lt; 5 × 10<sup>−6</sup>) (<a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Fig. 2</a>). Lead SNPs associated with HbA<sub>1c</sub> response (<em>P</em> &lt; 5 × 10<sup>−6</sup>) are presented in <a href="/pmc/articles/PMC6014560/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Tables 2</span></a>–<a href="/pmc/articles/PMC6014560/table/T4/" target="table" class="fig-table-link figpopup" rid-figpopup="T4" rid-ob="ob-T4" co-legend-rid=""><span>4</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC6014560/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139826682159120" class="figure"><a href="/pmc/articles/PMC6014560/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6014560_db171164f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is db171164f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6014560/bin/db171164f3.jpg"></a></div><div id="largeobj_idm139826682159120" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC6014560/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC6014560/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p23">HbA<sub>1c</sub> response to metformin treatment is diminished by SNPs in <em>NBEA</em>. <em>A</em>: Manhattan plot of HbA<sub>1c</sub> response to metformin treatment when all races were combined (<em>N</em> = 1,312). The horizontal dashed lines represent suggestive statistical significance (<em>P</em> = 5 × 10<sup>−6</sup>) (bottom line) and genome-wide significance (<em>P</em> = 5 × 10<sup>−8</sup>) (top line). Each point represents a single SNP. Genotyped SNPs are represented with black dots, imputed SNPs are represented by blue dots, and SNPs meta-analyzed from subjects genotyped in Set 1 subjects and imputed in Set 2 subjects are represented by pink dots. <em>B</em>: A LocusZoom (<a href="#B48" rid="B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306647">48</a>) plot demonstrating the lead SNP, rs57081354, association with change in HbA<sub>1c</sub> when all races are combined. Linkage disequilibrium was calculated using the 1000 Genomes reference panel using the hg19/1000 Genomes Nov 2014 EUR selection, matching the panel used to perform imputation in ACCORD. <em>C</em>: Forest plot demonstrating associations of rs57081354 in available replication cohorts. The β values for REP1 were changed to the additive inverse to maintain a consistent direction of effect. A larger β value means a diminished metformin response. Data for rs57081354 were not available for REP2 and REP3. Bars represent the 95% CIs. <em>D</em>: Change in HbA<sub>1c</sub> by rs57081354 genotype as represented by violin plots.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p24">Lead SNPs associated with HbA<sub>1c</sub> response in common variant analysis in all races combined (<em>P</em> &lt; 5 × 10<sup>−6</sup>)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139826680996288" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th scope="col" rowspan="1" colspan="1" align="left">SNP</th><th scope="col" rowspan="1" colspan="1" align="center">Chromosome</th><th scope="col" rowspan="1" colspan="1" align="center">Position</th><th scope="col" rowspan="1" colspan="1" align="center">Gene</th><th scope="col" rowspan="1" colspan="1" align="center">Type</th><th scope="col" rowspan="1" colspan="1" align="center">MAF</th><th scope="col" rowspan="1" colspan="1" align="center">β</th><th scope="col" rowspan="1" colspan="1" align="center"><em>P</em> value</th></tr></thead><tbody><tr><td scope="row" rowspan="1" colspan="1" align="left">rs7371352<hr></td><td rowspan="1" colspan="1" align="center">2<hr></td><td rowspan="1" colspan="1" align="center">205916609<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.461<hr></td><td rowspan="1" colspan="1" align="center">0.166<hr></td><td rowspan="1" colspan="1" align="center">1.29E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs12694529<hr></td><td rowspan="1" colspan="1" align="center">2<hr></td><td rowspan="1" colspan="1" align="center">220685415<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">META<hr></td><td rowspan="1" colspan="1" align="center">0.131<hr></td><td rowspan="1" colspan="1" align="center">0.232<hr></td><td rowspan="1" colspan="1" align="center">1.06E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs2371651<hr></td><td rowspan="1" colspan="1" align="center">3<hr></td><td rowspan="1" colspan="1" align="center">64899735<hr></td><td rowspan="1" colspan="1" align="center"><em>ADAMTS9-AS2</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.346<hr></td><td rowspan="1" colspan="1" align="center">0.171<hr></td><td rowspan="1" colspan="1" align="center">4.89E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs36050186<hr></td><td rowspan="1" colspan="1" align="center">3<hr></td><td rowspan="1" colspan="1" align="center">73884807<hr></td><td rowspan="1" colspan="1" align="center"><em>LOC105377165</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.061<hr></td><td rowspan="1" colspan="1" align="center">0.315<hr></td><td rowspan="1" colspan="1" align="center">4.46E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs28535480<hr></td><td rowspan="1" colspan="1" align="center">3<hr></td><td rowspan="1" colspan="1" align="center">144238665<hr></td><td rowspan="1" colspan="1" align="center"><em>LOC105374140</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.447<hr></td><td rowspan="1" colspan="1" align="center">0.184<hr></td><td rowspan="1" colspan="1" align="center">4.12E-07<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs7669299<hr></td><td rowspan="1" colspan="1" align="center">4<hr></td><td rowspan="1" colspan="1" align="center">77525989<hr></td><td rowspan="1" colspan="1" align="center"><em>CXCL13</em><hr></td><td rowspan="1" colspan="1" align="center">GENO<hr></td><td rowspan="1" colspan="1" align="center">0.106<hr></td><td rowspan="1" colspan="1" align="center">−0.348<hr></td><td rowspan="1" colspan="1" align="center">5.88E-07<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs79827403<hr></td><td rowspan="1" colspan="1" align="center">4<hr></td><td rowspan="1" colspan="1" align="center">140248372<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.046<hr></td><td rowspan="1" colspan="1" align="center">−0.386<hr></td><td rowspan="1" colspan="1" align="center">2.19E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs6884548<hr></td><td rowspan="1" colspan="1" align="center">5<hr></td><td rowspan="1" colspan="1" align="center">104706194<hr></td><td rowspan="1" colspan="1" align="center"><em>LOC105379109</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.038<hr></td><td rowspan="1" colspan="1" align="center">0.439<hr></td><td rowspan="1" colspan="1" align="center">2.64E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs56061109<hr></td><td rowspan="1" colspan="1" align="center">5<hr></td><td rowspan="1" colspan="1" align="center">113100738<hr></td><td rowspan="1" colspan="1" align="center"><em>MCC</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.048<hr></td><td rowspan="1" colspan="1" align="center">0.394<hr></td><td rowspan="1" colspan="1" align="center">6.00E-07<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs6903843<hr></td><td rowspan="1" colspan="1" align="center">6<hr></td><td rowspan="1" colspan="1" align="center">3125135<hr></td><td rowspan="1" colspan="1" align="center"><em>BPHL</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.031<hr></td><td rowspan="1" colspan="1" align="center">0.587<hr></td><td rowspan="1" colspan="1" align="center">3.36E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs79573377<hr></td><td rowspan="1" colspan="1" align="center">6<hr></td><td rowspan="1" colspan="1" align="center">91226278<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.033<hr></td><td rowspan="1" colspan="1" align="center">0.437<hr></td><td rowspan="1" colspan="1" align="center">3.19E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs59506474<hr></td><td rowspan="1" colspan="1" align="center">6<hr></td><td rowspan="1" colspan="1" align="center">136927217<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.066<hr></td><td rowspan="1" colspan="1" align="center">−0.355<hr></td><td rowspan="1" colspan="1" align="center">1.57E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs2578120<hr></td><td rowspan="1" colspan="1" align="center">10<hr></td><td rowspan="1" colspan="1" align="center">78453110<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.358<hr></td><td rowspan="1" colspan="1" align="center">−0.160<hr></td><td rowspan="1" colspan="1" align="center">2.53E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs7307035<hr></td><td rowspan="1" colspan="1" align="center">12<hr></td><td rowspan="1" colspan="1" align="center">53778761<hr></td><td rowspan="1" colspan="1" align="center"><em>LOC107984525</em><hr></td><td rowspan="1" colspan="1" align="center">META<hr></td><td rowspan="1" colspan="1" align="center">0.033<hr></td><td rowspan="1" colspan="1" align="center">−0.440<hr></td><td rowspan="1" colspan="1" align="center">1.77E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs12300320<hr></td><td rowspan="1" colspan="1" align="center">12<hr></td><td rowspan="1" colspan="1" align="center">93077216<hr></td><td rowspan="1" colspan="1" align="center"><em>LOC643339</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.053<hr></td><td rowspan="1" colspan="1" align="center">−0.386<hr></td><td rowspan="1" colspan="1" align="center">3.01E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs12827634<hr></td><td rowspan="1" colspan="1" align="center">12<hr></td><td rowspan="1" colspan="1" align="center">95026750<hr></td><td rowspan="1" colspan="1" align="center"><em>NR2C1</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.362<hr></td><td rowspan="1" colspan="1" align="center">0.154<hr></td><td rowspan="1" colspan="1" align="center">3.18E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs57081354<hr></td><td rowspan="1" colspan="1" align="center">13<hr></td><td rowspan="1" colspan="1" align="center">35202456<hr></td><td rowspan="1" colspan="1" align="center"><em>NBEA</em><hr></td><td rowspan="1" colspan="1" align="center">GENO<hr></td><td rowspan="1" colspan="1" align="center">0.077<hr></td><td rowspan="1" colspan="1" align="center">0.326<hr></td><td rowspan="1" colspan="1" align="center">4.02E-08<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs4144603<hr></td><td rowspan="1" colspan="1" align="center">14<hr></td><td rowspan="1" colspan="1" align="center">96729576<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">META<hr></td><td rowspan="1" colspan="1" align="center">0.405<hr></td><td rowspan="1" colspan="1" align="center">0.159<hr></td><td rowspan="1" colspan="1" align="center">1.36E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs7173199<hr></td><td rowspan="1" colspan="1" align="center">15<hr></td><td rowspan="1" colspan="1" align="center">29424654<hr></td><td rowspan="1" colspan="1" align="center"><em>FAM189A1</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.046<hr></td><td rowspan="1" colspan="1" align="center">0.419<hr></td><td rowspan="1" colspan="1" align="center">1.77E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs182384419<hr></td><td rowspan="1" colspan="1" align="center">15<hr></td><td rowspan="1" colspan="1" align="center">79438983<hr></td><td rowspan="1" colspan="1" align="center"><em>KIAA1024</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.043<hr></td><td rowspan="1" colspan="1" align="center">0.394<hr></td><td rowspan="1" colspan="1" align="center">2.66E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs74007109<hr></td><td rowspan="1" colspan="1" align="center">16<hr></td><td rowspan="1" colspan="1" align="center">6852072<hr></td><td rowspan="1" colspan="1" align="center"><em>RBFOX1</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.040<hr></td><td rowspan="1" colspan="1" align="center">0.407<hr></td><td rowspan="1" colspan="1" align="center">2.92E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs2529698<hr></td><td rowspan="1" colspan="1" align="center">17<hr></td><td rowspan="1" colspan="1" align="center">12350355<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">META<hr></td><td rowspan="1" colspan="1" align="center">0.061<hr></td><td rowspan="1" colspan="1" align="center">0.331<hr></td><td rowspan="1" colspan="1" align="center">9.24E-07<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs254271<hr></td><td rowspan="1" colspan="1" align="center">19<hr></td><td rowspan="1" colspan="1" align="center">54630757<hr></td><td rowspan="1" colspan="1" align="center"><em>PRPF31</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.330<hr></td><td rowspan="1" colspan="1" align="center">0.163<hr></td><td rowspan="1" colspan="1" align="center">3.79E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs6139020</td><td rowspan="1" colspan="1" align="center">20</td><td rowspan="1" colspan="1" align="center">3156571</td><td rowspan="1" colspan="1" align="center"><em>UBOX5</em></td><td rowspan="1" colspan="1" align="center">IMPU</td><td rowspan="1" colspan="1" align="center">0.102</td><td rowspan="1" colspan="1" align="center">0.257</td><td rowspan="1" colspan="1" align="center">3.08E-06</td></tr></tbody></table></div><div id="largeobj_idm139826680996288" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC6014560/table/T2/?report=objectonly">Open in a separate window</a></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="__p27">Lead SNPs associated with HbA<sub>1c</sub> response in common variant analysis in black subjects only (<em>P</em> &lt; 5 × 10<sup>−6</sup>)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139826682563552" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th scope="col" rowspan="1" colspan="1" align="left">SNP</th><th scope="col" rowspan="1" colspan="1" align="center">Chromosome</th><th scope="col" rowspan="1" colspan="1" align="center">Position</th><th scope="col" rowspan="1" colspan="1" align="center">Gene</th><th scope="col" rowspan="1" colspan="1" align="center">Type</th><th scope="col" rowspan="1" colspan="1" align="center">MAF</th><th scope="col" rowspan="1" colspan="1" align="center">β</th><th scope="col" rowspan="1" colspan="1" align="center"><em>P</em> value</th></tr></thead><tbody><tr><td scope="row" rowspan="1" colspan="1" align="left">rs7573365<hr></td><td rowspan="1" colspan="1" align="center">2<hr></td><td rowspan="1" colspan="1" align="center">183278246<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">META<hr></td><td rowspan="1" colspan="1" align="center">0.325<hr></td><td rowspan="1" colspan="1" align="center">−0.379<hr></td><td rowspan="1" colspan="1" align="center">3.67E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs12496540<hr></td><td rowspan="1" colspan="1" align="center">3<hr></td><td rowspan="1" colspan="1" align="center">32062976<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.352<hr></td><td rowspan="1" colspan="1" align="center">0.388<hr></td><td rowspan="1" colspan="1" align="center">4.98E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs62284968<hr></td><td rowspan="1" colspan="1" align="center">3<hr></td><td rowspan="1" colspan="1" align="center">197429996<hr></td><td rowspan="1" colspan="1" align="center"><em>LOC105374308</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.040<hr></td><td rowspan="1" colspan="1" align="center">1.066<hr></td><td rowspan="1" colspan="1" align="center">1.20E-07<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs9295608<hr></td><td rowspan="1" colspan="1" align="center">6<hr></td><td rowspan="1" colspan="1" align="center">23977533<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">GENO<hr></td><td rowspan="1" colspan="1" align="center">0.208<hr></td><td rowspan="1" colspan="1" align="center">−0.462<hr></td><td rowspan="1" colspan="1" align="center">1.35E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs111792250<hr></td><td rowspan="1" colspan="1" align="center">6<hr></td><td rowspan="1" colspan="1" align="center">136927930<hr></td><td rowspan="1" colspan="1" align="center"><em>SLC35D3</em><sup>a</sup><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.192<hr></td><td rowspan="1" colspan="1" align="center">−0.528<hr></td><td rowspan="1" colspan="1" align="center">7.97E-07<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs4413694<hr></td><td rowspan="1" colspan="1" align="center">7<hr></td><td rowspan="1" colspan="1" align="center">142430649<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.458<hr></td><td rowspan="1" colspan="1" align="center">−0.346<hr></td><td rowspan="1" colspan="1" align="center">4.43E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs201739756<hr></td><td rowspan="1" colspan="1" align="center">8<hr></td><td rowspan="1" colspan="1" align="center">73149128<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.054<hr></td><td rowspan="1" colspan="1" align="center">0.875<hr></td><td rowspan="1" colspan="1" align="center">2.04E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs145554029<hr></td><td rowspan="1" colspan="1" align="center">8<hr></td><td rowspan="1" colspan="1" align="center">77485920<hr></td><td rowspan="1" colspan="1" align="center"><em>LOC102724874</em><sup>b</sup><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.035<hr></td><td rowspan="1" colspan="1" align="center">−1.221<hr></td><td rowspan="1" colspan="1" align="center">8.76E-09<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs10897557<hr></td><td rowspan="1" colspan="1" align="center">11<hr></td><td rowspan="1" colspan="1" align="center">80135250<hr></td><td rowspan="1" colspan="1" align="center"><em>LOC105369406</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.319<hr></td><td rowspan="1" colspan="1" align="center">−0.432<hr></td><td rowspan="1" colspan="1" align="center">6.73E-07<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs7130041<hr></td><td rowspan="1" colspan="1" align="center">11<hr></td><td rowspan="1" colspan="1" align="center">128552747<hr></td><td rowspan="1" colspan="1" align="center"><em>ETS1</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.348<hr></td><td rowspan="1" colspan="1" align="center">−0.406<hr></td><td rowspan="1" colspan="1" align="center">3.02E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs76853142<hr></td><td rowspan="1" colspan="1" align="center">13<hr></td><td rowspan="1" colspan="1" align="center">93580057<hr></td><td rowspan="1" colspan="1" align="center"><em>GPC6</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.041<hr></td><td rowspan="1" colspan="1" align="center">−0.940<hr></td><td rowspan="1" colspan="1" align="center">4.54E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs1449836<hr></td><td rowspan="1" colspan="1" align="center">14<hr></td><td rowspan="1" colspan="1" align="center">42994192<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">META<hr></td><td rowspan="1" colspan="1" align="center">0.471<hr></td><td rowspan="1" colspan="1" align="center">−0.353<hr></td><td rowspan="1" colspan="1" align="center">1.43E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs62072150<hr></td><td rowspan="1" colspan="1" align="center">17<hr></td><td rowspan="1" colspan="1" align="center">73412120<hr></td><td rowspan="1" colspan="1" align="center"><em>SDK2</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.451<hr></td><td rowspan="1" colspan="1" align="center">−0.423<hr></td><td rowspan="1" colspan="1" align="center">4.12E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs185341538<hr></td><td rowspan="1" colspan="1" align="center">19<hr></td><td rowspan="1" colspan="1" align="center">32981426<hr></td><td rowspan="1" colspan="1" align="center"><em>RHPN2</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.291<hr></td><td rowspan="1" colspan="1" align="center">−0.428<hr></td><td rowspan="1" colspan="1" align="center">2.99E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs34600526</td><td rowspan="1" colspan="1" align="center">19</td><td rowspan="1" colspan="1" align="center">33504770</td><td rowspan="1" colspan="1" align="center">NA</td><td rowspan="1" colspan="1" align="center">IMPU</td><td rowspan="1" colspan="1" align="center">0.295</td><td rowspan="1" colspan="1" align="center">−0.395</td><td rowspan="1" colspan="1" align="center">4.49E-06</td></tr></tbody></table></div><div id="largeobj_idm139826682563552" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC6014560/table/T4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="t4n1"><p id="__p28" class="p p-first-last"><sup>a</sup>rs111792250 does not fall in <em>SLC35D3</em>, but rs7763578 (<em>P</em> = 1.47 × 10<sup>−6</sup>) is in the same peak and is located in <em>SLC35D3</em>.</p></div><div id="t4n2"><p id="__p29" class="p p-first-last"><sup>b</sup>rs145554029 does not fall in <em>LOC102724874</em>, but rs75121529 (<em>P</em> = 1.22 × 10<sup>−8</sup>) is in the same peak and is located in <em>LOC102724874</em>.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p25">Lead SNPs associated with HbA<sub>1c</sub> response in common variant analysis in white subjects only (<em>P</em> &lt; 5 × 10<sup>−6</sup>)</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139826685753456" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead valign="bottom"><tr><th scope="col" rowspan="1" colspan="1" align="left">SNP</th><th scope="col" rowspan="1" colspan="1" align="center">Chromosome</th><th scope="col" rowspan="1" colspan="1" align="center">Position</th><th scope="col" rowspan="1" colspan="1" align="center">Gene</th><th scope="col" rowspan="1" colspan="1" align="center">Type</th><th scope="col" rowspan="1" colspan="1" align="center">MAF</th><th scope="col" rowspan="1" colspan="1" align="center">β</th><th scope="col" rowspan="1" colspan="1" align="center"><em>P</em> value</th></tr></thead><tbody><tr><td scope="row" rowspan="1" colspan="1" align="left">rs12047072<hr></td><td rowspan="1" colspan="1" align="center">1<hr></td><td rowspan="1" colspan="1" align="center">97401162<hr></td><td rowspan="1" colspan="1" align="center"><em>DPYD</em><hr></td><td rowspan="1" colspan="1" align="center">META<hr></td><td rowspan="1" colspan="1" align="center">0.184<hr></td><td rowspan="1" colspan="1" align="center">−0.215<hr></td><td rowspan="1" colspan="1" align="center">4.66E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs13034779<hr></td><td rowspan="1" colspan="1" align="center">2<hr></td><td rowspan="1" colspan="1" align="center">234091216<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.305<hr></td><td rowspan="1" colspan="1" align="center">0.239<hr></td><td rowspan="1" colspan="1" align="center">6.24E-07<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs2371651<hr></td><td rowspan="1" colspan="1" align="center">3<hr></td><td rowspan="1" colspan="1" align="center">64899735<hr></td><td rowspan="1" colspan="1" align="center"><em>ADAMTS9-AS2</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.431<hr></td><td rowspan="1" colspan="1" align="center">0.192<hr></td><td rowspan="1" colspan="1" align="center">3.71E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs36050186<hr></td><td rowspan="1" colspan="1" align="center">3<hr></td><td rowspan="1" colspan="1" align="center">73884807<hr></td><td rowspan="1" colspan="1" align="center"><em>LOC105377165</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.082<hr></td><td rowspan="1" colspan="1" align="center">0.332<hr></td><td rowspan="1" colspan="1" align="center">2.47E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs71140472<hr></td><td rowspan="1" colspan="1" align="center">3<hr></td><td rowspan="1" colspan="1" align="center">144248959<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.461<hr></td><td rowspan="1" colspan="1" align="center">0.177<hr></td><td rowspan="1" colspan="1" align="center">3.30E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs2929535<hr></td><td rowspan="1" colspan="1" align="center">8<hr></td><td rowspan="1" colspan="1" align="center">67754375<hr></td><td rowspan="1" colspan="1" align="center"><em>CPA6</em><sup>a</sup><hr></td><td rowspan="1" colspan="1" align="center">META<hr></td><td rowspan="1" colspan="1" align="center">0.307<hr></td><td rowspan="1" colspan="1" align="center">−0.188<hr></td><td rowspan="1" colspan="1" align="center">3.47E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs111976192<hr></td><td rowspan="1" colspan="1" align="center">8<hr></td><td rowspan="1" colspan="1" align="center">83716899<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.267<hr></td><td rowspan="1" colspan="1" align="center">0.195<hr></td><td rowspan="1" colspan="1" align="center">4.99E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs10904150<hr></td><td rowspan="1" colspan="1" align="center">10<hr></td><td rowspan="1" colspan="1" align="center">3970713<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.072<hr></td><td rowspan="1" colspan="1" align="center">−0.336<hr></td><td rowspan="1" colspan="1" align="center">4.66E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs4567482<hr></td><td rowspan="1" colspan="1" align="center">11<hr></td><td rowspan="1" colspan="1" align="center">134474052<hr></td><td rowspan="1" colspan="1" align="center"><em>LOC283177</em><hr></td><td rowspan="1" colspan="1" align="center">META<hr></td><td rowspan="1" colspan="1" align="center">0.123<hr></td><td rowspan="1" colspan="1" align="center">−0.286<hr></td><td rowspan="1" colspan="1" align="center">1.66E-07<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs7298631<hr></td><td rowspan="1" colspan="1" align="center">12<hr></td><td rowspan="1" colspan="1" align="center">95063515<hr></td><td rowspan="1" colspan="1" align="center"><em>NR2C1</em><hr></td><td rowspan="1" colspan="1" align="center">IMPU<hr></td><td rowspan="1" colspan="1" align="center">0.397<hr></td><td rowspan="1" colspan="1" align="center">0.176<hr></td><td rowspan="1" colspan="1" align="center">4.51E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs4775474<hr></td><td rowspan="1" colspan="1" align="center">15<hr></td><td rowspan="1" colspan="1" align="center">62150069<hr></td><td rowspan="1" colspan="1" align="center">NA<hr></td><td rowspan="1" colspan="1" align="center">META<hr></td><td rowspan="1" colspan="1" align="center">0.355<hr></td><td rowspan="1" colspan="1" align="center">0.189<hr></td><td rowspan="1" colspan="1" align="center">2.07E-06<hr></td></tr><tr><td scope="row" rowspan="1" colspan="1" align="left">rs182384419</td><td rowspan="1" colspan="1" align="center">15</td><td rowspan="1" colspan="1" align="center">79438983</td><td rowspan="1" colspan="1" align="center"><em>KIAA1024</em></td><td rowspan="1" colspan="1" align="center">IMPU</td><td rowspan="1" colspan="1" align="center">0.054</td><td rowspan="1" colspan="1" align="center">0.503</td><td rowspan="1" colspan="1" align="center">1.53E-08</td></tr></tbody></table></div><div id="largeobj_idm139826685753456" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC6014560/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="t3n1"><p id="__p26" class="p p-first-last"><sup>a</sup>rs2929535 does not fall in <em>CPA6</em>, but rs2162145 (<em>P</em> = 4.04 × 10<sup>−6</sup>) is in the same peak and is located in <em>CPA6</em>.</p></div></div></div></div><div id="s14" class="sec"><h3 id="s14title">Rare Variant Analysis</h3><p id="__p30" class="p p-first-last">Rare variants (MAF ≤0.03) in a total of 17,078 genes were tested for association with HbA<sub>1c</sub> in all subjects combined and separately in white and black subjects. In the combined subject analysis, rare variants in <em>STAT3</em> were significantly associated with HbA<sub>1c</sub> response (<em>q</em> &lt;0.1) (<a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Fig. 3</a>). Five rare variants were available for testing in <em>STAT3</em>: rs146620441 (monomorphic), rs140604473 (missense), rs149214040 (missense), rs114401618 (intronic), and rs17882069 (synonymous) (<a href="#B28" rid="B28" class=" bibr popnode">28</a>). Importantly, rs146620441 was monomorphic and the other four SNPs only showed variation in black subjects, although there were no statistically significant rare variant associations observed in race-based analyses (<em>q</em> &gt;0.2). We tested whether <em>STAT3</em> failed to yield significant associations in the stratified analysis due to the small number of black subjects (<em>n</em> = 222) by oversampling black subjects until we had the same number of subjects as when all races were combined (<em>n</em> = 1,312). Oversampling to build a larger cohort resulted in a <em>q</em> = 0.0016 versus a <em>q</em> = 1 in the original cohort of black subjects, supporting the premise that this rare variant finding is relevant for black subjects even though it was detected when all subjects were combined due to an increase in statistical power.</p></div><div id="s15" class="sec"><h3 id="s15title">Association With Dietary Phenotypes</h3><p id="__p31" class="p p-first-last">NBEA has been previously reported to influence sugary food preference in animal models (<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306644">29</a>), and we further assessed whether the lead SNP in this locus, rs57081354, was associated with dietary scores. Data were available in 1,553 ACCORD subjects (<a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 6</a>). The C-allele in rs57081354 that associated with worse metformin effect also associated with increased consumption of dessert (<em>q</em> = 0.12). Subjects with the C-allele in rs57081354 were more likely to answer “Yes” to the question, “Did you eat dessert?” within past 3 months (β = 0.044 [95% CI 0.012, 0.075]).</p></div><div id="s16" class="sec sec-last"><h3 id="s16title">Replication</h3><p id="__p32" class="p p-first">A total of 134 unique SNPs were associated with metformin response (<em>P</em> &lt; 5 × 10<sup>−6</sup>) when all races were combined, in white subjects only, and in black subjects only. Of these SNPs, 81, 64, and 61 were available in REP1, REP2, and REP3 cohorts, respectively. The most significant finding in the discovery cohort was rs57081354 located in the <em>NBEA</em> gene (<em>P</em> = 4.02 × 10<sup>−8</sup>, β = 0.323). This finding did not replicate in REP1 (<em>P</em> &gt; 0.05) and was not available for testing in REP2 or REP3. Out of the 26 SNPs in <em>NBEA</em> with <em>P</em> &lt; 1 × 10<sup>−6</sup>, only rs1337379 was tested in REP2 and REP3 but was not associated with metformin response (<em>P</em> &gt; 0.05). SNPs in <em>NBEA</em> were not significantly associated with metformin response in ACCORD when black or white subjects were tested separately, only when all races were combined. Interestingly, in the set of subjects who were already on metformin when they enrolled in ACCORD (REP4), rs57081354, was marginally associated with higher baseline HbA<sub>1c</sub> (<em>P</em> = 0.09), whereas rs57081354 was not associated with baseline variation in HbA<sub>1c</sub> in those not on metformin (<em>P</em> = 0.63). Although the phenotypes for REP1 and REP4 are not identical, meta-analysis of the ACCORD discovery cohort with REP1 and REP4 produced an association representing higher HbA<sub>1c</sub> on metformin (<em>P</em> = 0.009) (<a href="/pmc/articles/PMC6014560/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a>).</p><p id="__p33">In ACCORD, rs254271, located in an intron in pre-mRNA processing factor 31 (<em>PRPF31</em>), was associated with worse metformin response when all races were combined (<em>P</em> = 3.79 × 10<sup>−6</sup>). In the REP1 cohort, rs254271 was associated with worse metformin response when corrected for baseline HbA<sub>1c</sub> (<em>P</em> = 6.21 × 10<sup>−5</sup>) and without adjusting for baseline HbA<sub>1c</sub> (<em>P</em> = 1.57 × 10<sup>−2</sup>). Genotypes for rs254271 were not available for analysis in the African American replication cohorts, REP2 and REP3. Meta-analysis of ACCORD with REP1 produced a significant association for rs254271 with worse metformin response (<em>P</em> = 1.2 × 10<sup>−8</sup>) (<a href="/pmc/articles/PMC6014560/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC6014560/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139826679175296" class="figure"><a href="/pmc/articles/PMC6014560/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=6014560_db171164f4.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is db171164f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC6014560/bin/db171164f4.jpg"></a></div><div id="largeobj_idm139826679175296" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC6014560/figure/F4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC6014560/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p34">Forest plot of associations with replicated SNPs in REP1, REP2, and REP3. <em>A</em>: Discovery and replication results for rs2162145, located in the <em>CPA6</em> gene. <em>B</em>: Discovery and replication results for rs254271, an intronic variant in <em>PRPF31</em>. A larger β value means a diminished metformin response. The β values for REP1 were changed to the additive inverse to maintain a consistent direction of effect. Bars represent the 95% CIs.</p></div></div></div><p id="__p35" class="p p-last">In white subjects in ACCORD, rs2162145, located in carboxypeptidase A6 (<em>CPA6</em>), was associated with better metformin response (<em>P</em> = 4.04 × 10<sup>−6</sup>). This finding was consistent with findings in African American subjects in REP2 (<em>P</em> = 0.006). Although, rs2162145 was not significantly associated with metformin response in black subjects in ACCORD (<em>P</em> = 0.14), it is possible that we were underpowered to detect an association due to the relatively small number of black subjects available (<em>n</em> = 222) and that meta-analysis could increase statistical power through the inclusion of additional subjects. Meta-analysis of black subjects in ACCORD and those in REP2 and REP3 demonstrated the most significant association of rs2162145 with better metformin response (<em>P</em> = 0.005) compared with meta-analysis of all white subjects (ACCORD white subjects and REP1) and all cohorts (ACCORD, REP1–3) with <em>P</em> = 0.22 and <em>P</em> = 0.09, respectively (<a href="/pmc/articles/PMC6014560/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4</span></a>).</p></div></div><div id="s17" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="s17title">Discussion</h2><p id="__p36" class="p p-first">T2D adversely affects the quality of life for millions of individuals and places a significant burden on the health care system in the U.S. and globally (<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306628">30</a>,<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306636">31</a>). Although many treatment options for T2D are available, metformin has remained the first-line treatment for T2D for decades. Nevertheless, the mechanisms by which metformin lowers blood glucose are not well understood, and factors that may predict which patients will have optimal responses to metformin are also not well understood. Here, we use a GWAS approach in a large cohort of individuals with T2D in the ACCORD clinical trial to test for both common and rare variant SNPs that associate with change in HbA<sub>1c</sub> level in response to metformin treatment. To support our initial findings, we explored these associations in multiple independent cohorts.</p><p id="__p37">A previous study conducted in a large cohort using electronic medical records found that African American patients on metformin had a larger reduction in HbA<sub>1c</sub> than European Americans (<a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306642">32</a>). We failed to find a significant difference between metformin response in white subjects and black subjects in ACCORD, with changes in HbA<sub>1c</sub> of −1.47% and −1.35%, respectively (<em>P</em> = 0.16). It is possible that enrollment in a more structured clinical trial impacts these outcomes differently than the far less structured care reflected in electronic medical record data. Additional research will be needed to definitely characterize the response of metformin across ethnicities. Previous GWAS have identified rs11212617 in the <em>ATM</em> locus and rs8192675 in <em>SLC2A2</em> as being significantly associated with metformin response (<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306652">12</a>,<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306653">13</a>). However, neither SNP was significantly associated with metformin response here (<em>P</em> &gt; 0.1). These SNPs may have failed to replicate in the current study due to cohort differences and, in particular, the sample size of the ACCORD cohort and the use of concomitant medications. Information regarding the prescribed dose for metformin was not recorded in ACCORD and may have impacted our findings. However, as described in <a href="#s2" rid="s2" class=" sec">r<span class="small-caps">esearch</span> d<span class="small-caps">esign and</span> m<span class="small-caps">ethods</span></a>, we sought a minimal time window to assess the response of metformin while limiting the likelihood of other medication changes. Additional details about how these studies compare with ACCORD can be found in the <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Data</a>.</p><p id="__p38">In the analysis of subjects from all racial groups combined (<em>n</em> = 1,312) (<a href="/pmc/articles/PMC6014560/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>), those with the C-allele of rs254271, an intronic variant in <em>PRPF31</em>, had a worse metformin response at suggestive significance levels (<em>P</em> = 3.79 × 10<sup>−6</sup>, β = 0.16). The effect of this variant was also observed in REP1, consisting of subjects of European ancestry (<em>P</em> = 6.21 × 10<sup>−5</sup>, β = −0.073). Interestingly, rs254271 is an expression quantitative trait locus in several tissues for PRPF31 and nearby genes, including NADH:ubiquinone oxidoreductase (NDUFA3), which codes for a subunit of the complex I of the respiratory chain (<a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306641">33</a>–<a href="#B35" rid="B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306640">35</a>). Metformin is known to inhibit complex I of the respiratory chain to cause AMPK activation (<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306638">5</a>). In addition, previous studies have shown that <em>PRPF31</em>(+/−) knockout mice have increased total body fat (<em>P</em> = 1.78 × 10<sup>−6</sup>) and increased fasted circulating glucose (<em>P</em> = 5.73 × 10<sup>−6</sup>) (<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306625">36</a>).</p><p id="__p39">Genotypes for rs254271 were not available for analysis in the African American replication cohorts, REP2 and REP3. The phenotype in REP1 represents HbA<sub>1c</sub> reduction, so the direction of the effect for rs254271 is consistent between ACCORD and REP1 and represents worse HbA<sub>1c</sub> response in individuals with the C-allele (<a href="/pmc/articles/PMC6014560/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4</span></a>). Mutations in <em>PRPF31</em> have been associated with an autosomal dominant rare Mendelian disease, retinitis pigmentosa (<a href="#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306623">37</a>). <em>PRPF31</em> was previously identified as a candidate gene for diabetic retinopathy in a genome-wide linkage study in Mexican Americans with T2D (<a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306648">38</a>). We tested rs254271 for association with eye disorders in ACCORD; however, no significant associations were found (<em>P</em> &gt; 0.05) (data not shown). Further research will be needed to determine what role SNPs in <em>PRPF31</em> may have in metformin drug response or in diabetic retinopathy.</p><p id="__p40">In the analysis of only white subjects in ACCORD, rs2162145, in the <em>CPA6</em> gene, was associated with metformin response at suggestive significance levels (<em>P</em> = 4.04 × 10<sup>−6</sup>, β = −0.197). This same SNP was associated with metformin response in the REP2 cohort (<em>P</em> = 0.006, β = −0.127), but not in REP1 or REP3 (<em>P</em> &gt; 0.05) (<a href="/pmc/articles/PMC6014560/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4</span></a>). To our knowledge, SNPs in <em>CPA6</em> have not previously been associated with metformin response; however, rs2162145 has a weak significant association with fasting glucose (<em>P</em> = 0.02) (<a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306651">39</a>). In addition, a meta-analysis of T2D in 17 GWAS comprising 8,284 case and 15,543 control subjects in African Americans identified rs7003257, an intron variant in <em>CPA6</em>, as being associated with T2D (<em>P</em> = 1.17 × 10<sup>−6</sup>) (<a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306630">40</a>), and this SNP has also been previously reported to affect 2-h glucose levels (<a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306637">41</a>). We were underpowered to detect an association in black subjects. However, meta-analyzing all available black subjects in ACCORD, REP2, and REP3 improved the statistical power so an association was detectable (<em>P</em> = 0.005). It will be necessary for additional studies to investigate the extent to which <em>CPA6</em> is involved with metformin drug response.</p><p id="__p41">A genotyped SNP in the <em>NBEA</em> gene on chr13 rs57081354 was associated with change in HbA<sub>1c</sub> levels at genome-wide significance (<em>P</em> = 4.02 × 10<sup>−8</sup>, β = 0.323) in our discovery cohort (<a href="/pmc/articles/PMC6014560/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a>). SNPs in <em>NBEA</em> did not replicate in REP1–3 cohorts. rs57081354 was marginally associated with baseline HbA<sub>1c</sub> levels in individuals who were taking metformin at the time they enrolled in ACCORD, with the C-allele displaying higher HbA<sub>1c</sub> values (<em>P</em> = 0.09) (<a href="/pmc/articles/PMC6014560/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3<em>C</em></span></a>). NBEA is a protein kinase A anchor protein that is expressed at low levels ubiquitously and at higher levels in the brain, pituitary, and β-cells in the pancreas (<a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306645">42</a>). Interestingly, haplotype-insufficient <em>Nbea</em>(+/−) mice prefer sugary foods (glucose and fructose) more than their wild-type controls, gain more weight per unit of food than wild-type mice, and have higher insulin and leptin levels (<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306639">29</a>). Subsequently, we tested for associations between rs57081354 and 19 dietary scores recorded for a subset of 1,553 ACCORD subjects and found that rs57081354 was associated with an increase in dessert consumption (<em>q</em> &lt;0.2) in those with C-allele (<a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 6</a>). An expanded summary of the literature regarding <em>NBEA</em> can be found in the <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Data</a>.</p><p id="__p42">Additionally, we tested rare variants for associations with change in HbA<sub>1c</sub>, and <em>STAT3</em> when all races were combined, was the only gene that achieved statistical significance for metformin treatment response (<em>q</em> &lt;0.1). However, as described in <a href="#s12" rid="s12" class=" sec"><span class="small-caps">r</span>esults</a>, black subjects were the only population with rare variation in <em>STAT3</em>, and <em>STAT3</em> was not detected in the stratified analysis likely due to the small number of subjects available for analysis (<em>n</em> = 222). In this same cohort, rare variants in <em>STAT3</em> were not associated with baseline HbA<sub>1c</sub> levels (<em>q</em> &gt;0.2). <em>STAT3</em> encodes a ubiquitously expressed transcription factor with broad activities in metabolism, immunity, and cell growth (<a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306627">43</a>). STAT3 is an essential signal transducer for the key metabolic hormone leptin and the pleiotropic cytokine interleukin 6 with broad effects on feeding behavior and fuel homeostasis. Interestingly, metformin has been shown to interact with STAT3 signaling in chemotherapeutic applications and in an inflammatory bowel disease model (<a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306657">44</a>–<a href="#B47" rid="B47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_708306646">47</a>). To our knowledge, interactions between metformin and STAT3 signaling have not been investigated with regard to glucose homeostasis.</p><p id="__p43" class="p p-last">Here, we present evidence for <em>PRPF31, CPA6</em>, and <em>STAT3</em> being involved in novel glucose-lowering mechanisms for metformin. Additional investigation will also be required to confirm the clinical impact of the identified variants with regard to metformin therapy in subjects with diabetes. Although prior studies suggest roles for <em>NBEA</em> and <em>STAT3</em> genes in glucose metabolism, additional research will be required to investigate mechanisms by which they might interact with metformin. Such studies are likely to provide new insight into mechanisms regulating glucose metabolism and may point the way toward novel therapeutic targets for more precise interventions in T2D.</p></div><div id="__sec1" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="PMC_1">

<!--caption a9--><strong>Supplementary Data:</strong>

<div class="sup-box half_rhythm" id="idm139826679520048"><a href="/pmc/articles/PMC6014560/bin/DB171164SupplementaryData.pdf" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(800K, pdf)</sup></div>
</div></div><div id="idm139826691819008" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139826691819008title">Article Information</h2><div class="sec"><p id="__p45"><strong>Funding.</strong> This research was supported by National Heart, Lung, and Blood Institute grants 5R01HL110380-04 to the University of North Carolina at Chapel Hill and R01 HL110400 to the Joslin Diabetes Center and the University of Virginia. S.W.Y. and K.M.G. were supported by grants from the National Institutes of Health (GM61390 and <a id="__tag_783235522" class="tag_hotlink" href="/nuccore/GM117163" ref="/nuccore/GM117163"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"GM117163","term_id":"222043936","term_text":"GM117163"}}</span>GM117163</a>). E.R.P. holds a Wellcome Trust Investigator Award (102820/Z/13/Z).</p><p id="__p46"><strong>Duality of Interest.</strong> No potential conflicts of interest relevant to this article were reported.</p><p id="__p47"><strong>Author Contributions.</strong> D.M.R., S.W.Y., M.A.H., H.L.M., M.J.W., J.B.B., and A.A.M.-R. wrote the article. D.M.R., M.M.H., M.K., J.C.M., H.L.M., A.D., K.M.G., E.R.P., M.J.W., J.B.B., and A.A.M.-R. designed the research. D.M.R., S.W.Y., K.Z., S.W.M., H.S.H., T.M.H., H.G., M.J.W., and A.A.M.-R. performed the research. D.M.R., S.W.Y., K.Z., S.W.M., and J.R.J. analyzed the data. A.A.M.-R. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p><p id="__p48"><strong>Prior Presentation.</strong> Parts of this study were presented in abstract form at the American Society for Clinical Pharmacology &amp; Therapeutics Annual Meeting, Washington, DC, 15–18 March 2017.</p></div></div><div id="idm139826693312560" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139826693312560title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn1"></p><p id="__p44" class="p p-first-last">This article contains Supplementary Data online at <a href="http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db17-1164/-/DC1</a>.</p><p></p></div></div><div id="idm139826689501568" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139826689501568title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="mixed-citation">Centers for Disease Control and Prevention 
<span class="ref-journal">National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014</span>. Atlanta, GA, U.S. Department of Health and Human Services, 2014 <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=National+Diabetes+Statistics+Report:+Estimates+of+Diabetes+and+Its+Burden+in+the+United+States,+2014&amp;publication_year=2014&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="mixed-citation">World Health Organization. Global report on diabetes [Internet], 2017. Available from <a href="http://www.who.int/diabetes/global-report/en/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.who.int/diabetes/global-report/en/</a>. Accessed 28 April 2018</span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="mixed-citation">Mozaffarian D, Benjamin EJ, Go AS, et al. .; American Heart Association Statistics Committee; Stroke Statistics Subcommittee. <span class="ref-title">Heart disease and stroke statistics—2016 update. A report from the American Heart Association</span>. <span class="ref-journal">Circulation</span>
2016;133:e38–e360 [<a href="/pubmed/26673558" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Heart+disease+and+stroke+statistics—2016+update.+A+report+from+the+American+Heart+Association&amp;author=D+Mozaffarian&amp;author=EJ+Benjamin&amp;author=AS+Go&amp;publication_year=2016&amp;pmid=26673558&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="mixed-citation">Rena G, Pearson ER, Sakamoto K.
<span class="ref-title">Molecular mechanism of action of metformin: old or new insights?</span>
<span class="ref-journal">Diabetologia</span>
2013;<span class="ref-vol">56</span>:1898–1906 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3737434/">PMC free article</a>]</span> [<a href="/pubmed/23835523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Molecular+mechanism+of+action+of+metformin:+old+or+new+insights?&amp;author=G+Rena&amp;author=ER+Pearson&amp;author=K+Sakamoto&amp;volume=56&amp;publication_year=2013&amp;pages=1898-1906&amp;pmid=23835523&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="mixed-citation">Zhou G, Myers R, Li Y, et al. 
<span class="ref-title">Role of AMP-activated protein kinase in mechanism of metformin action</span>. <span class="ref-journal">J Clin Invest</span>
2001;<span class="ref-vol">108</span>:1167–1174 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC209533/">PMC free article</a>]</span> [<a href="/pubmed/11602624" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Role+of+AMP-activated+protein+kinase+in+mechanism+of+metformin+action&amp;author=G+Zhou&amp;author=R+Myers&amp;author=Y+Li&amp;volume=108&amp;publication_year=2001&amp;pages=1167-1174&amp;pmid=11602624&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="mixed-citation">Foretz M, Hébrard S, Leclerc J, et al. 
<span class="ref-title">Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state</span>. <span class="ref-journal">J Clin Invest</span>
2010;<span class="ref-vol">120</span>:2355–2369 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2898585/">PMC free article</a>]</span> [<a href="/pubmed/20577053" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Metformin+inhibits+hepatic+gluconeogenesis+in+mice+independently+of+the+LKB1/AMPK+pathway+via+a+decrease+in+hepatic+energy+state&amp;author=M+Foretz&amp;author=S+Hébrard&amp;author=J+Leclerc&amp;volume=120&amp;publication_year=2010&amp;pages=2355-2369&amp;pmid=20577053&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="mixed-citation">Buse JB, DeFronzo RA, Rosenstock J, et al. 
<span class="ref-title">The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies</span>. <span class="ref-journal">Diabetes Care</span>
2016;<span class="ref-vol">39</span>:198–205 [<a href="/pubmed/26285584" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Care&amp;title=The+primary+glucose-lowering+effect+of+metformin+resides+in+the+gut,+not+the+circulation:+results+from+short-term+pharmacokinetic+and+12-week+dose-ranging+studies&amp;author=JB+Buse&amp;author=RA+DeFronzo&amp;author=J+Rosenstock&amp;volume=39&amp;publication_year=2016&amp;pages=198-205&amp;pmid=26285584&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="mixed-citation">McCreight LJ, Bailey CJ, Pearson ER.
<span class="ref-title">Metformin and the gastrointestinal tract</span>. <span class="ref-journal">Diabetologia</span>
2016;<span class="ref-vol">59</span>:426–435 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4742508/">PMC free article</a>]</span> [<a href="/pubmed/26780750" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Metformin+and+the+gastrointestinal+tract&amp;author=LJ+McCreight&amp;author=CJ+Bailey&amp;author=ER+Pearson&amp;volume=59&amp;publication_year=2016&amp;pages=426-435&amp;pmid=26780750&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="mixed-citation">Baur JA, Birnbaum MJ.
<span class="ref-title">Control of gluconeogenesis by metformin: does redox trump energy charge?</span>
<span class="ref-journal">Cell Metab</span>
2014;<span class="ref-vol">20</span>:197–199 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4154964/">PMC free article</a>]</span> [<a href="/pubmed/25100057" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab&amp;title=Control+of+gluconeogenesis+by+metformin:+does+redox+trump+energy+charge?&amp;author=JA+Baur&amp;author=MJ+Birnbaum&amp;volume=20&amp;publication_year=2014&amp;pages=197-199&amp;pmid=25100057&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="mixed-citation">Ferrannini E.
<span class="ref-title">The target of metformin in type 2 diabetes</span>. <span class="ref-journal">N Engl J Med</span>
2014;<span class="ref-vol">371</span>:1547–1548 [<a href="/pubmed/25317875" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=The+target+of+metformin+in+type+2+diabetes&amp;author=E+Ferrannini&amp;volume=371&amp;publication_year=2014&amp;pages=1547-1548&amp;pmid=25317875&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="mixed-citation">Zhou K, Donnelly L, Yang J, et al. .; Wellcome Trust Case Control Consortium 2 .
<span class="ref-title">Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis</span>. <span class="ref-journal">Lancet Diabetes Endocrinol</span>
2014;<span class="ref-vol">2</span>:481–487 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4038749/">PMC free article</a>]</span> [<a href="/pubmed/24731673" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Diabetes+Endocrinol&amp;title=Heritability+of+variation+in+glycaemic+response+to+metformin:+a+genome-wide+complex+trait+analysis&amp;author=K+Zhou&amp;author=L+Donnelly&amp;author=J+Yang&amp;volume=2&amp;publication_year=2014&amp;pages=481-487&amp;pmid=24731673&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="mixed-citation">Zhou K, Yee SW, Seiser EL, et al. .; MetGen Investigators; DPP Investigators; ACCORD Investigators .
<span class="ref-title">Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin</span>. <span class="ref-journal">Nat Genet</span>
2016;<span class="ref-vol">48</span>:1055–1059 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5007158/">PMC free article</a>]</span> [<a href="/pubmed/27500523" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Variation+in+the+glucose+transporter+gene+SLC2A2+is+associated+with+glycemic+response+to+metformin&amp;author=K+Zhou&amp;author=SW+Yee&amp;author=EL+Seiser&amp;volume=48&amp;publication_year=2016&amp;pages=1055-1059&amp;pmid=27500523&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="mixed-citation">Zhou K, Bellenguez C, Spencer CC, et al. .; GoDARTS and UKPDS Diabetes Pharmacogenetics Study Group; Wellcome Trust Case Control Consortium 2; MAGIC Investigators .
<span class="ref-title">Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes</span>. <span class="ref-journal">Nat Genet</span>
2011;<span class="ref-vol">43</span>:117–120 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3030919/">PMC free article</a>]</span> [<a href="/pubmed/21186350" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Common+variants+near+ATM+are+associated+with+glycemic+response+to+metformin+in+type+2+diabetes&amp;author=K+Zhou&amp;author=C+Bellenguez&amp;author=CC+Spencer&amp;volume=43&amp;publication_year=2011&amp;pages=117-120&amp;pmid=21186350&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="mixed-citation">Buse JB, Bigger JT, Byington RP, et al. .; ACCORD Study Group .
<span class="ref-title">Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods</span>. <span class="ref-journal">Am J Cardiol</span>
2007;<span class="ref-vol">99</span>(<span class="ref-iss">Suppl.</span>):21i–33i [<a href="/pubmed/17599422" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Cardiol&amp;title=Action+to+Control+Cardiovascular+Risk+in+Diabetes+(ACCORD)+trial:+design+and+methods&amp;author=JB+Buse&amp;author=JT+Bigger&amp;author=RP+Byington&amp;volume=99&amp;issue=Suppl.&amp;publication_year=2007&amp;pages=21i-33i&amp;pmid=17599422&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="mixed-citation">Goff DC Jr, Gerstein HC, Ginsberg HN, et al. .; ACCORD Study Group .
<span class="ref-title">Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial</span>. <span class="ref-journal">Am J Cardiol</span>
2007;<span class="ref-vol">99</span>:4i–20i [<a href="/pubmed/17599424" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Cardiol&amp;title=Prevention+of+cardiovascular+disease+in+persons+with+type+2+diabetes+mellitus:+current+knowledge+and+rationale+for+the+Action+to+Control+Cardiovascular+Risk+in+Diabetes+(ACCORD)+trial&amp;author=DC+Goff&amp;author=HC+Gerstein&amp;author=HN+Ginsberg&amp;volume=99&amp;publication_year=2007&amp;pages=4i-20i&amp;pmid=17599424&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="mixed-citation">Gerstein HC, Riddle MC, Kendall DM, et al. .; ACCORD Study Group .
<span class="ref-title">Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial</span>. <span class="ref-journal">Am J Cardiol</span>
2007;<span class="ref-vol">99</span>:34i–43i [<a href="/pubmed/17599423" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Cardiol&amp;title=Glycemia+treatment+strategies+in+the+Action+to+Control+Cardiovascular+Risk+in+Diabetes+(ACCORD)+trial&amp;author=HC+Gerstein&amp;author=MC+Riddle&amp;author=DM+Kendall&amp;volume=99&amp;publication_year=2007&amp;pages=34i-43i&amp;pmid=17599423&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="mixed-citation">Ginsberg HN, Bonds DE, Lovato LC, et al. .; ACCORD Study Group .
<span class="ref-title">Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial</span>. <span class="ref-journal">Am J Cardiol</span>
2007;<span class="ref-vol">99</span>:56i–67i [<a href="/pubmed/17599426" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Cardiol&amp;title=Evolution+of+the+lipid+trial+protocol+of+the+Action+to+Control+Cardiovascular+Risk+in+Diabetes+(ACCORD)+trial&amp;author=HN+Ginsberg&amp;author=DE+Bonds&amp;author=LC+Lovato&amp;volume=99&amp;publication_year=2007&amp;pages=56i-67i&amp;pmid=17599426&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="mixed-citation">Graham HT, Rotroff DM, Marvel SW, et al.; ACCORD/ACCORDion Investigators. Incorporating concomitant medications into genome-wide analyses for the study of complex disease and drug response. Front Genet 2016;7:138 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5013254/">PMC free article</a>]</span> [<a href="/pubmed/27775101" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="mixed-citation">Marvel SW, Rotroff DM, Wagner MJ, et al.; ACCORD/ACCORDion Investigators. Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trial. PeerJ 2017;5:e3187 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5417062/">PMC free article</a>]</span> [<a href="/pubmed/28480134" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="mixed-citation">R Development Core Team. <em>R: A Language and Environment for Statistical Computing.</em> R Foundation for Statistical Computing, Vienna, Austria, 2014</span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="mixed-citation">Purcell S, Neale B, Todd-Brown K, et al. 
<span class="ref-title">PLINK: a tool set for whole-genome association and population-based linkage analyses</span>. <span class="ref-journal">Am J Hum Genet</span>
2007;<span class="ref-vol">81</span>:559–575 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;volume=81&amp;publication_year=2007&amp;pages=559-575&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="mixed-citation">Shaun Purcell. PLINK v1.07 [Internet], 2009. Available from <a href="http://zzz.bwh.harvard.edu/plink/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://zzz.bwh.harvard.edu/plink/</a>. Accessed 28 April 2018</span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="mixed-citation">Dai H, Leeder JS, Cui Y. A modified generalized Fisher method for combining probabilities from dependent tests. Front Genet 2014;5:32 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3929847/">PMC free article</a>]</span> [<a href="/pubmed/24600471" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="mixed-citation">Dabney A, Storey JD, Warnes G.
<span class="ref-title">Q-value estimation for false discovery rate control</span>. <span class="ref-journal">Medicine (Baltimore)</span>
2004;<span class="ref-vol">344</span>:539–548 <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Medicine+(Baltimore)&amp;title=Q-value+estimation+for+false+discovery+rate+control&amp;author=A+Dabney&amp;author=JD+Storey&amp;author=G+Warnes&amp;volume=344&amp;publication_year=2004&amp;pages=539-548&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="mixed-citation">Storey JD.
<span class="ref-title">A direct approach to false discovery rates</span>. <span class="ref-journal">J R Stat Soc Series B Stat Methodol</span>
2002;<span class="ref-vol">64</span>:479–498 <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+R+Stat+Soc+Series+B+Stat+Methodol&amp;title=A+direct+approach+to+false+discovery+rates&amp;author=JD+Storey&amp;volume=64&amp;publication_year=2002&amp;pages=479-498&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="mixed-citation">Goswami S, Yee SW, Xu F, et al. 
<span class="ref-title">A longitudinal HbA1c model elucidates genes linked to disease progression on metformin</span>. <span class="ref-journal">Clin Pharmacol Ther</span>
2016;<span class="ref-vol">100</span>:537–547 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5534241/">PMC free article</a>]</span> [<a href="/pubmed/27415606" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther&amp;title=A+longitudinal+HbA1c+model+elucidates+genes+linked+to+disease+progression+on+metformin&amp;author=S+Goswami&amp;author=SW+Yee&amp;author=F+Xu&amp;volume=100&amp;publication_year=2016&amp;pages=537-547&amp;pmid=27415606&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="mixed-citation">Banda Y, Kvale MN, Hoffmann TJ, et al. 
<span class="ref-title">Characterizing race/ethnicity and genetic ancestry for 100,000 subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort</span>. <span class="ref-journal">Genetics</span>
2015;<span class="ref-vol">200</span>:1285–1295 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4574246/">PMC free article</a>]</span> [<a href="/pubmed/26092716" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Characterizing+race/ethnicity+and+genetic+ancestry+for+100,000+subjects+in+the+Genetic+Epidemiology+Research+on+Adult+Health+and+Aging+(GERA)+cohort&amp;author=Y+Banda&amp;author=MN+Kvale&amp;author=TJ+Hoffmann&amp;volume=200&amp;publication_year=2015&amp;pages=1285-1295&amp;pmid=26092716&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="mixed-citation">National Center for Biotechnology Information, National Library of Medicine. Database of single nucleotide polymorphisms (dbSNP) [Internet], 2017. Available from <a href="http://www.ncbi.nlm.nih.gov/SNP/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/SNP/</a>. Accessed 12 November 2017</span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="mixed-citation">Olszewski PK, Rozman J, Jacobsson JA, et al. 
<span class="ref-title">Neurobeachin, a regulator of synaptic protein targeting, is associated with body fat mass and feeding behavior in mice and body-mass index in humans</span>. <span class="ref-journal">PLoS Genet</span>
2012;<span class="ref-vol">8</span>:e1002568. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3305408/">PMC free article</a>]</span> [<a href="/pubmed/22438821" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Neurobeachin,+a+regulator+of+synaptic+protein+targeting,+is+associated+with+body+fat+mass+and+feeding+behavior+in+mice+and+body-mass+index+in+humans&amp;author=PK+Olszewski&amp;author=J+Rozman&amp;author=JA+Jacobsson&amp;volume=8&amp;publication_year=2012&amp;pages=e1002568&amp;pmid=22438821&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="mixed-citation">da Rocha Fernandes J, Ogurtsova K, Linnenkamp U, et al. 
<span class="ref-title">IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes</span>. <span class="ref-journal">Diabetes Res Clin Pract</span>
2016;<span class="ref-vol">117</span>:48–54 [<a href="/pubmed/27329022" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes+Res+Clin+Pract&amp;title=IDF+Diabetes+Atlas+estimates+of+2014+global+health+expenditures+on+diabetes&amp;author=J+da+Rocha+Fernandes&amp;author=K+Ogurtsova&amp;author=U+Linnenkamp&amp;volume=117&amp;publication_year=2016&amp;pages=48-54&amp;pmid=27329022&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="mixed-citation">Danaei G, Finucane MM, Lu Y, et al. .; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose) 
<span class="ref-title">National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants</span>. <span class="ref-journal">Lancet</span>
2011;<span class="ref-vol">378</span>:31–40 [<a href="/pubmed/21705069" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=National,+regional,+and+global+trends+in+fasting+plasma+glucose+and+diabetes+prevalence+since+1980:+systematic+analysis+of+health+examination+surveys+and+epidemiological+studies+with+370+country-years+and+2.7+million+participants&amp;author=G+Danaei&amp;author=MM+Finucane&amp;author=Y+Lu&amp;volume=378&amp;publication_year=2011&amp;pages=31-40&amp;pmid=21705069&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="mixed-citation">Williams LK, Padhukasahasram B, Ahmedani BK, et al. 
<span class="ref-title">Differing effects of metformin on glycemic control by race-ethnicity</span>. <span class="ref-journal">J Clin Endocrinol Metab</span>
2014;<span class="ref-vol">99</span>:3160–3168 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4154100/">PMC free article</a>]</span> [<a href="/pubmed/24921653" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=Differing+effects+of+metformin+on+glycemic+control+by+race-ethnicity&amp;author=LK+Williams&amp;author=B+Padhukasahasram&amp;author=BK+Ahmedani&amp;volume=99&amp;publication_year=2014&amp;pages=3160-3168&amp;pmid=24921653&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="mixed-citation">Zeller T, Wild P, Szymczak S, et al. 
<span class="ref-title">Genetics and beyond--the transcriptome of human monocytes and disease susceptibility</span>. <span class="ref-journal">PLoS One</span>
2010;<span class="ref-vol">5</span>:e10693. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2872668/">PMC free article</a>]</span> [<a href="/pubmed/20502693" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Genetics+and+beyond--the+transcriptome+of+human+monocytes+and+disease+susceptibility&amp;author=T+Zeller&amp;author=P+Wild&amp;author=S+Szymczak&amp;volume=5&amp;publication_year=2010&amp;pages=e10693&amp;pmid=20502693&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="mixed-citation">GTEx Consortium 
<span class="ref-title">The Genotype-Tissue Expression (GTEx) project</span>. <span class="ref-journal">Nat Genet</span>
2013;<span class="ref-vol">45</span>:580–585 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4010069/">PMC free article</a>]</span> [<a href="/pubmed/23715323" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=The+Genotype-Tissue+Expression+(GTEx)+project&amp;volume=45&amp;publication_year=2013&amp;pages=580-585&amp;pmid=23715323&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="mixed-citation">Owen MR, Doran E, Halestrap AP.
<span class="ref-title">Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain</span>. <span class="ref-journal">Biochem J</span>
2000;<span class="ref-vol">348</span>:607–614 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1221104/">PMC free article</a>]</span> [<a href="/pubmed/10839993" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J&amp;title=Evidence+that+metformin+exerts+its+anti-diabetic+effects+through+inhibition+of+complex+1+of+the+mitochondrial+respiratory+chain&amp;author=MR+Owen&amp;author=E+Doran&amp;author=AP+Halestrap&amp;volume=348&amp;publication_year=2000&amp;pages=607-614&amp;pmid=10839993&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="mixed-citation">Brown SDM, Moore MW; The International Mouse Phenotyping Consortium .
<span class="ref-title">The International Mouse Phenotyping Consortium: past and future perspectives on mouse phenotyping</span>. <span class="ref-journal">Mamm Genome</span>
2012;<span class="ref-vol">23</span>:632–640 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3774932/">PMC free article</a>]</span> [<a href="/pubmed/22940749" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mamm+Genome&amp;title=The+International+Mouse+Phenotyping+Consortium:+past+and+future+perspectives+on+mouse+phenotyping&amp;author=SDM+Brown&amp;author=MW+Moore&amp;volume=23&amp;publication_year=2012&amp;pages=632-640&amp;pmid=22940749&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="mixed-citation">Waseem NH, Vaclavik V, Webster A, Jenkins SA, Bird AC, Bhattacharya SS.
<span class="ref-title">Mutations in the gene coding for the pre-mRNA splicing factor, PRPF31, in patients with autosomal dominant retinitis pigmentosa</span>. <span class="ref-journal">Invest Ophthalmol Vis Sci</span>
2007;<span class="ref-vol">48</span>:1330–1334 [<a href="/pubmed/17325180" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Invest+Ophthalmol+Vis+Sci&amp;title=Mutations+in+the+gene+coding+for+the+pre-mRNA+splicing+factor,+PRPF31,+in+patients+with+autosomal+dominant+retinitis+pigmentosa&amp;author=NH+Waseem&amp;author=V+Vaclavik&amp;author=A+Webster&amp;author=SA+Jenkins&amp;author=AC+Bird&amp;volume=48&amp;publication_year=2007&amp;pages=1330-1334&amp;pmid=17325180&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="mixed-citation">Hallman DM, Boerwinkle E, Gonzalez VH, Klein BEK, Klein R, Hanis CL.
<span class="ref-title">A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas</span>. <span class="ref-journal">Diabetes</span>
2007;<span class="ref-vol">56</span>:1167–1173 [<a href="/pubmed/17251272" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=A+genome-wide+linkage+scan+for+diabetic+retinopathy+susceptibility+genes+in+Mexican+Americans+with+type+2+diabetes+from+Starr+County,+Texas&amp;author=DM+Hallman&amp;author=E+Boerwinkle&amp;author=VH+Gonzalez&amp;author=BEK+Klein&amp;author=R+Klein&amp;volume=56&amp;publication_year=2007&amp;pages=1167-1173&amp;pmid=17251272&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="mixed-citation">Dupuis J, Langenberg C, Prokopenko I, et al. .; DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Procardis Consortium; MAGIC Investigators .
<span class="ref-title">New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk</span>. <span class="ref-journal">Nat Genet</span>
2010;<span class="ref-vol">42</span>:105–116 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3018764/">PMC free article</a>]</span> [<a href="/pubmed/20081858" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=New+genetic+loci+implicated+in+fasting+glucose+homeostasis+and+their+impact+on+type+2+diabetes+risk&amp;author=J+Dupuis&amp;author=C+Langenberg&amp;author=I+Prokopenko&amp;volume=42&amp;publication_year=2010&amp;pages=105-116&amp;pmid=20081858&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="mixed-citation">Ng MCY, Shriner D, Chen BH, et al. .; FIND Consortium; eMERGE Consortium; DIAGRAM Consortium; MuTHER Consortium; MEta-analysis of type 2 DIabetes in African Americans Consortium .
<span class="ref-title">Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes</span>. <span class="ref-journal">PLoS Genet</span>
2014;<span class="ref-vol">10</span>:e1004517. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4125087/">PMC free article</a>]</span> [<a href="/pubmed/25102180" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Meta-analysis+of+genome-wide+association+studies+in+African+Americans+provides+insights+into+the+genetic+architecture+of+type+2+diabetes&amp;author=MCY+Ng&amp;author=D+Shriner&amp;author=BH+Chen&amp;volume=10&amp;publication_year=2014&amp;pages=e1004517&amp;pmid=25102180&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="mixed-citation">Saxena R, Hivert M-F, Langenberg C, et al. .; GIANT consortium; MAGIC Investigators .
<span class="ref-title">Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge</span>. <span class="ref-journal">Nat Genet</span>
2010;<span class="ref-vol">42</span>:142–148 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2922003/">PMC free article</a>]</span> [<a href="/pubmed/20081857" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genetic+variation+in+GIPR+influences+the+glucose+and+insulin+responses+to+an+oral+glucose+challenge&amp;author=R+Saxena&amp;author=M-F+Hivert&amp;author=C+Langenberg&amp;volume=42&amp;publication_year=2010&amp;pages=142-148&amp;pmid=20081857&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="mixed-citation">Uhlén M, Fagerberg L, Hallström BM, et al. 
<span class="ref-title">Proteomics. Tissue-based map of the human proteome</span>. <span class="ref-journal">Science</span>
2015;<span class="ref-vol">347</span>:1260419. [<a href="/pubmed/25613900" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Proteomics.+Tissue-based+map+of+the+human+proteome&amp;author=M+Uhlén&amp;author=L+Fagerberg&amp;author=BM+Hallström&amp;volume=347&amp;publication_year=2015&amp;pages=1260419&amp;pmid=25613900&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="mixed-citation">Johnston PA, Grandis JR.
<span class="ref-title">STAT3 signaling: anticancer strategies and challenges</span>. <span class="ref-journal">Mol Interv</span>
2011;<span class="ref-vol">11</span>:18–26 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3063716/">PMC free article</a>]</span> [<a href="/pubmed/21441118" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Interv&amp;title=STAT3+signaling:+anticancer+strategies+and+challenges&amp;author=PA+Johnston&amp;author=JR+Grandis&amp;volume=11&amp;publication_year=2011&amp;pages=18-26&amp;pmid=21441118&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="mixed-citation">Deng X-S, Wang S, Deng A, et al. 
<span class="ref-title">Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers</span>. <span class="ref-journal">Cell Cycle</span>
2012;<span class="ref-vol">11</span>:367–376 [<a href="/pubmed/22189713" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Cycle&amp;title=Metformin+targets+Stat3+to+inhibit+cell+growth+and+induce+apoptosis+in+triple-negative+breast+cancers&amp;author=X-S+Deng&amp;author=S+Wang&amp;author=A+Deng&amp;volume=11&amp;publication_year=2012&amp;pages=367-376&amp;pmid=22189713&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="mixed-citation">Feng Y, Ke C, Tang Q, et al. 
<span class="ref-title">Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling</span>. <span class="ref-journal">Cell Death Dis</span>
2014;<span class="ref-vol">5</span>:e1088. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3944271/">PMC free article</a>]</span> [<a href="/pubmed/24577086" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Death+Dis&amp;title=Metformin+promotes+autophagy+and+apoptosis+in+esophageal+squamous+cell+carcinoma+by+downregulating+Stat3+signaling&amp;author=Y+Feng&amp;author=C+Ke&amp;author=Q+Tang&amp;volume=5&amp;publication_year=2014&amp;pages=e1088&amp;pmid=24577086&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="mixed-citation">Tan X-L, Bhattacharyya KK, Dutta SK, et al. 
<span class="ref-title">Metformin suppresses pancreatic tumor growth with inhibition of NFκB/STAT3 inflammatory signaling</span>. <span class="ref-journal">Pancreas</span>
2015;<span class="ref-vol">44</span>:636–647 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4399019/">PMC free article</a>]</span> [<a href="/pubmed/25875801" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pancreas&amp;title=Metformin+suppresses+pancreatic+tumor+growth+with+inhibition+of+NFκB/STAT3+inflammatory+signaling&amp;author=X-L+Tan&amp;author=KK+Bhattacharyya&amp;author=SK+Dutta&amp;volume=44&amp;publication_year=2015&amp;pages=636-647&amp;pmid=25875801&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="mixed-citation">Lee S-Y, Lee SH, Yang E-J, et al. 
<span class="ref-title">Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the between Th17/Treg balance</span>. <span class="ref-journal">PLoS One</span>
2015;<span class="ref-vol">10</span>:e0135858. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4567351/">PMC free article</a>]</span> [<a href="/pubmed/26360050" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Metformin+ameliorates+inflammatory+bowel+disease+by+suppression+of+the+STAT3+signaling+pathway+and+regulation+of+the+between+Th17/Treg+balance&amp;author=S-Y+Lee&amp;author=SH+Lee&amp;author=E-J+Yang&amp;volume=10&amp;publication_year=2015&amp;pages=e0135858&amp;pmid=26360050&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="mixed-citation">Pruim RJ, Welch RP, Sanna S, et al. 
<span class="ref-title">LocusZoom: regional visualization of genome-wide association scan results</span>. <span class="ref-journal">Bioinformatics</span>
2010;<span class="ref-vol">26</span>:2336–2337 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2935401/">PMC free article</a>]</span> [<a href="/pubmed/20634204" target="pmc_ext" ref="reftype=pubmed&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=LocusZoom:+regional+visualization+of+genome-wide+association+scan+results&amp;author=RJ+Pruim&amp;author=RP+Welch&amp;author=S+Sanna&amp;volume=26&amp;publication_year=2010&amp;pages=2336-2337&amp;pmid=20634204&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=6014560&amp;issue-id=315752&amp;journal-id=582&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm139826690703824title">Abstract</a></li><li><a href="#s1title">Introduction</a></li><li><a href="#s2title">Research Design and Methods</a></li><li><a href="#s12title">Results</a></li><li><a href="#s17title">Discussion</a></li><li><a href="#__sec1title">Supplementary Material</a></li><li><a href="#idm139826691819008title">Article Information</a></li><li><a href="#idm139826693312560title">Footnotes</a></li><li><a href="#idm139826689501568title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Diabetes</span> are provided here courtesy of <strong>American Diabetes Association</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC6014560/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC6014560/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC6014560/pdf/db171164.pdf">PDF (1.4M)</a></li> | <li><a href="#" data-citationid="PMC6014560" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6014560%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6014560%2F&amp;text=Genetic%20Variants%20in%20CPA6%20and%20PRPF31%20Are%20Associated%20With%20Variation%20in%20Response%20to%20Metformin%20in%20Individuals%20With%20Type%202%20Diabetes" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6014560%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="29650774" data-aiid="6014560" data-aid="6014560" data-iid="315752" data-domainid="582" data-domain="diabetes" data-accid="PMC6014560" data-md5="94e7aff1aaa4c98142e477047fc7fb90"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T17:08:53-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal101&amp;ncbi_phid=CE88B3FEDD5AF39100000000060203A2&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6014560%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=diabetes&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC6014560/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>